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The phenomenon of fluorescence was first
reported by Sir David Brewster, being mentioned in a
paper "On the Colours of Natural Bodies" (Brewster, 1833)
read before the Royal Society of Edinburgh and described
at length before the British Association at Newcastle
(Brewster, 1838), Particular reference was made by him
to the striking colour to be seen in a particular variety
of fluor-spar on illumination with an invisible part of
the spectrum of sunlight. Sir John Herschel presented
his observations "On a Case of Superficial Colour
presented by a Homogeneous Liquid Internally Colourless"
(Herschel, 1845) which was followed by a further paper
by Brewster (1846) on the subject of "The Epipolic
Dispersion of Light".
The detailed paper by Professor G.G. Stokes
"On the Change in the Refrangibility of Light" reported
the role of ultraviolet light in relation to quinine,
chlorophyll and other organic materials with the optical
phenomenon being christened "dispersive reflexion"
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although in a footnote he wrote, "I confess I do not
like this term. I am almost inclined to coin a word
and call the appearance fluorescence from fluor-spar,
as the analagous term opalescence is derived from the
name of a mineral". Thus although the term fluorescence
was first coined by Stokes (1852) to whom is usually
attributed the discovery of the phenomenon, the credit
should be that of Sir David Brewster (1781 - 1868) whose
life-long research into the science of optics culminated
in his appointment as Vice-Chancellor of the University
of Edinburgh in 1860, and as President of the Royal
Society of Edinburgh in 1864.
CURRENT THEORY OF FLUORESCENCE
Current theories of the absorption and
emission of radiation combine the classical and quantum
theories of optics with the quantum mechanical theory of
atomic and molelecular structure.
Light is a form of electromagnetic radiation
(energy), the propagation of which may be regarded as
a wave phenomenon, being characterised by a frequency
(v), a wavelength (A)» and, in a vacuum, a constant





When light enters matter, it may pass through
with only little absorption talcing place, the material
then being considered essentially transparent. There
is a little loss of energy, but the velocity of the
light is diminished appreciably. The refractive
index of a substance is the ratio of the velocity of
light in a vacuum to the velocity in that substance.
Alternatively, light on its passage through
a medium may be absorbed either entirely or in part, a
process which involves a transfer of energy to the
medium. This absorption is s highly specific
phenomenon dependent on the particular energy of the
radiation and the molecular structure of the medium.
According to quantum theory, energy from light is
absorbed in integral units, called quanta. The energy




where h is Planck's constant, 6.62 x 10~c<r erg-seconds,
c the velocity of light, v the vibration frequency
(second and \ the wavelength. Wavelength is
commonly quoted in Angstrom units or millimicrons (mja.)
•ft
1 Angstrom unit - 10 cm. « 10 millimicrons
Uach molecule possesses a series of closely
spaced energy levels and can pass from a lower energy
level to a higher one by absorbing an integral quantum
of light which is equal to the difference between the
two energy states. All of the light which is absorbed
at any one instant, by a liquid solution containing
many molecules is taken up by only a few molecules, and
only those few are therefore promoted to an "excited"
state and are capable of fluorescing or undergoing
photochemical change. The relationship between energy
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The emission of light by molecules following
selective absorption of energy is referred to as
luminescence. Heat, electricity and chemical reaction,
as well as light, can bring about molecular excitation
leading to luminescence. Fluorescence and phosphor-
escence are the two types of luminescence following
excitation due to the absorption of any form of
electromagnetic radiation. Phosphorescence differs
from fluorescence by the persistence of the luminescence
following excitation by the light source and by a marked
enhancement and increase of the emission time with a
lowering of temperature.
The molecule, capable of fluorescence, absorbs
a photon of light, being left in an "excited state".
If the molecule does not decompose as a result of the
increase in energy, and if all the energy is not
dissipated by subsequent collisions with other molecules,
q n
then after a short period of time, 10 to 10second,
which is characteristic of the atom or molecule, the
electron returns to a lower energy level, emitting a
photon in the process. The difference between the
energy of the initial state and the final state determines
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the energy of the emitted radiation, which we call
fluorescence. The emitted fluorescence has a greater
wavelength or lower energy than the light which is
absorbed (Stoke's Law). A small amount of energy is
dissipated as heat (thermal deactivation) in the
overall process.
Fluorescence is characterised by specific
excitation (or activation) spectra and fluorescence
(or emission) spectra. The excitation spectrum will
differ from the fluorescence spectrum as a result of
instrumental artefacts. As an approximation the
fluorescence spectrum has been considered by some as
the mirror image of the absorption spectrum. There
are many examples, such as anthracene, which makes this
plausible. However, most polyatomic molecules in
aqueous solution have only one fluorescent band which
is associated with the absorption band of longest
wavelength. When such molecules are excited by light
coincident with an absorption band at shorter wave¬
length, the excited molecules undergo internal
conversion with loss of sufficient energy so as to pass
over into the state corresponding to the longest wave
absorption band.
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The two requisites for fluorescence are the
ability of the molecule to absorb light and the
presence on the resonating molecules of at least one
electron-donating substituent. Thus while benzene is
non-fluorescent, phenol and aniline are strong
fluorophores (substances capable of fluorescence).
Acetylation of aromatic amino or phenolic groups results
in total loss of fluorescence, while alkylation has
little or no effect, indicating that the substituent
requirement is for a group capable of increasing the
electron density of the aromatic molecules. Folycyclic
aromatic systems and aliphatic conjugated polyenes
comprise a second general classification of fluorophores
which require no additional substituents. Examination
of the formula of the tetracyclines given later (Fig»2)
show that they fulfil the requirements of a fluorophore
in that they are polycyclic aromatic systems and in




Although any electromagnetic radiation may
induce fluorescence, the most usual wavelengths
utilised are in the ultraviolet range.
The International Commission on Illumination
defined visible radiation for practical purposes as the
range of wavelengths between 3*800 and 7*800 Angstrom
(380 and 780 mp.). Ultraviolet radiation is usually
defined as electromagnetic radiation of wavelength
between 4-0 and 4000 A. (4 & 400 rap.). It bridges the
gap between the longest wavelength X-rays and tne
shortest wavelengths of light visible to the human eye,
although the limits of the visible spectrum are not
very clearly defined, varying with age and from one
individual to another.
The most efficient and useful sources of
ultraviolet are the arcs which occur when a current of
electricity is passed between electrodes separated by
a gas or vapour. The passage of current through the
gas results in various phenomena, one of which is the
emission of radiation. The amount of radiation which
lies in the ultraviolet varies with the nature of the
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arc. The commonly available source of artificial, as
opposed to solar, ultraviolet light is the enclosed
mercury vapour lamp. Such lamps are usually to be
found in any hospital, being used for therapy in the
physiotherapy departments and by the dermatologists
for the diagnosis of ringworm. Although the usual
mercury vapour lamp with a Wood's filter is readily
available it is not the most efficient source of
ultraviolet light for the purpose of exciting TC
fluorescence (see later). The emission spectrum of a
mercury-vapour arc is of the band type as shown in
Fig.l. For ultraviolet fluorescent work, a filter
glass in front of the mercury vapour lamp cuts out
practically the whole of the visible spectrum, although
it is transparent to most of the ultraviolet region.
Thus the induoed fluorescence contrasts with the faint
blue light emitted from the ultraviolet source.
Convenient lamps (of which a range are made
by Engelhard Hanovia Lamps of Slough) provide a medium-
pressure mercury-vapour arc enclosed in a quartz
envelope and emitting the full characteristic mercury
spectrum as shown in Fig.l. A filter glass, Chance's
11
OX 1, is designed to transmit the longer ultraviolet
rays and to exclude as far as possible all visible
radiation, thus its main transmission is from 300 to
400 mp. with the major spectral line of mercury being
in the region of 366 mp. Such a portable laqip was
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Fig. 1. ENERGY DISTRIBUTION IN THE VARIOUS
LINES OF THE SPECTRUM OF A TYPICAL
MEDIUM PRESSURE QUARTZ MERCURY ARC.
Section II
THE TETRACYCLINE GROUP OF DRUGS
Tetracycline (TC), the most important of the
broad spectrum antibiotics, was first referred to by
Stephens et al» (1952). These authors demonstrated
the chemical structures of "Terramycin" and "Aureomycin"
and proposed the name tetrac.ycline for the basic
structure common to both compounds. They assigned the
name ox.ytetrac.ycline (OTC) to "Terramycin" because of
the presence of an hydroxy group in position 5 of the
basic molecule. "Aureomycin" having a chloride
group in position 7 and lacking an hydroxy group in
position $ was later assigned the name chlortetracyline
(CTC).
The TC drugs became available commercially
in November, 1955 and were later produced by a direct
fermentation process.
There have been many modifications of the
basic TC molecule but the commonly used antibiotics
include TC, OTC, CTC and, more recently,
demethylchlortetracycline (DJffTC). The formulae of
these drugs is shown in Fig.2.
The antibacterial action of this group of
drugs does not concern this thesis, suffice it to say
14





















Fig. 2. CHEMICAL STRUCTURE OF FOUR TETRACYCLINE
ANTIBIOTICS
that their action is mainly bacteriostatic and that
the wide antibacterial range of action is remarkably
similar fcr the group of drugs.
ADMINISTRATION
From the voluminous literature it is difficult
to obtain any clear idea of the blood levels achieved
after a given dose of any of the TC group of antitiotics.
The difficulty is that the four major TC drugs, although
possessing virtually identical antimicrobial spectra,
differ in their relative activity against different
organisms. The usual methods of assay are against the
staphylococcus and bacillus cereus either by broth
dilutioh or agar diffusion. These assay methods tend to
minimise the effects of protein binding, the degree of
which varies with each of the drugs. Furthermore,
maximum antimicrobial activity is dependent on pH of the
culture mediums used. Consequent upon these difficulties,
comparisons between the blood levels achieved by the
different antibiotics is extremely difficult to assess,
although the fluorometric methods of assay recently
introduced should give more accurate measurements
(Ibsen et al.. 1963; Kohn, 1961a).
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As the antibiotic used in the current
investigation is TC, figures will be given for blood
levels of this drug given by different routes. The
derivatives OTC and CTC usually follow the same
pattern, but in the case of DMTC the blood levels tend
to remain higher for a longer period due to differences
in protein-binding, absorption and excretion.
Ora 1
Combining the results of several workers,
Dowling (1955) reports serum levels in adults receiving
250 and 500 rag. by mouth at 6 hour intervals. With
the smaller dosage regime there was a gradual rise to
between 2 and 4 jug./ml. by 5 days, whereas with $00 rag.
dosage a level of 4- jug./ml was achieved within 5 or A
days. At about this level, even though the drug be
continued, there is no further build-up in serum levels.
After a single dose of 500 mg. TC an average serum
level of about 5.5 jug./ml. is achieved in 5 hours, which
is higher than with the other 5 derivatives
(Kunin & Finland, 1961) a feature which may be of
importance in the choice of antibiotic for uptake by
tumours as described later.
Intravenous
After a single intravenous infusion of 500 mg.
of TC Kunin et al. (1959) found a mean level of 8 ^ug./ml
and by 24 hours the concentration was under 1 yUg./ml.,
whereas DMTC was appreciably higher. It should be
stressed however that there was an extremely large
scatter in the serum levels, which was even more marked
after an infusion of 1000 nig. (Finland et al., 1954)
but of the order of 16 to 32 ^ig./ml.
Intramuscular
Intramuscular injections of TC appear to be
fairly unsatisfactory for therapeutic purposes if given
in the usual doses of about 2.5 mg./kg. body weight, but
if 10 mg./kg. doses are used, levels of between 0.6 and
5.0 pg./ml. can be achieved. There is however fairly
considerable injection site pain with the higher dosage
regime. (Spies et al.« 1955)*
DISTRIBUTION
TC can be found in all body fluids after oral
or parenteral administration including pleural and
ascitic fluids, although there is some difficulty in
diffusion into the cerebrospinal fluid unless high
blood concentrations are achieved (Bowling, 1955).
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EXCRETION
Some 20 to 60#; of a dose of TC is excreted
in the urine within 24 hours (Maynard et al., 1953)*
There is a high biliary concentration, 5 to 10 times
that of the serum (Andriola, 1954), and there is a
hepato-intestinal circulation for this drug. Maynard
et al. (1953) report a fairly high excretion of the
antibiotic in the stool, although as their results
are simply given as milligrams per gram of wet stool,
the percentage faecal excretion cannot be determined.
Sweeney et al. (I960) reporting on DMTC showed that
from 23 to 72% of an oral dose was excreted in the
faeces and similar variable results are to be expected
with the other TC antibiotics.
FLUORESCENT FRGFERTIES
Udenfriend et al. (1957) demonstrated the
fluorescent properties of TC and OTC which have
excitation maxima at 390 mjx• and fluorescence maxima at
515 to 520 mp. at pH 11. The fluorescent character¬
istics of CTC were reported as 355 excitation and
445 mp. fluorescence, maximal at pH 11. It appears
that the fluorescence reported for CTC is, in part, due
to a derived product isochlortetracycline (Fig.2.) to
which the antibiotic is rapidly converted in basic
solution or at neutral pH (Levine et al., 1949.,
Chiccarelli et al., 1956). According to Feldman et al
(1957) the derived product has an excitation or
absorption maximum of 350 up. and a fluorescence
maximum of about 425 mol, (blue).
It has been demonstrated, by Hattner & Frost
(1962) that weak alcoholic or aqueous solutions of the
tetracyclines do not show strong fluorescence, but when
allowed to dry on an inert material they fluoresce
intensely. The suggested explanation for these
phenomena is that a hydration shell surrounding the TC
molecule in aqueous solutions quenches the fluorescence
as does an acid pH.
All the native tetracyclines fluoresce a
distinctive golden-.yellow. which is easily recognisable
and provides a ready means of identifying the presence
of the drug. Since the excitation maximum of TC is at
390 rap., whereas the major spectral line for mercury is
about 360 mp. (Fig.l.) the mercury vapour lamp is not a
very efficient source of ultraviolet light for the
exhibition of TO fluorescence* Nevertheless the
mercury vapour lamp provides a readily available,
cheap and convenient instrument for the study of the
presence and distribution of gross TO fluorescence.
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Section III
TETRACYCLINE FLUORESCENCE IN BIOLOGICAL TISSUES
General Discussion
The fluorescent property of TC was first used
in biological material by Bottiger (1955) to trace the
absorption, distribution and excretion of the
antibiotic in mice. He found that excretion was by
the kidney, liver and gastro-intestinal tract with
complete disappearance of the drug in 12 to 24 hours
from all organs except bone, where retention occurred.
As will be described later, TC is fixed and
retained by a variety of animal and human tissues, and
this property is shared by its derivatives, CTC, OTC
and DMTC. The physiological and diseased tissues
sharing this property include various malignant tumours,
bone, teeth, parasites, mitochondria, acute pancreatitis
and other inflammatory or necrotic lesions, as will be
discussed later.
This thesis is based on the phenomenon of
TC fixation in tumours and the demonstration of this
property by fluorescence induced by ultraviolet light.
As the mechanisms involved may help to elucidate the
mode of deposition and fixation of the drug in tumours,
details will be given of the same property in relation
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to non-malignant tissue. The demonstration of the
phenomenon is by the fluorescent property of the drug
in whatever tissue it may be laid down, so it seems
necessary to discuss, as well as malignant disease,
the other sites of deposition.
PART I
EERSONAL STUDIES OF TETRACYCLINE FLUORESCENCE
IN TUMOURS
Introduction
The study was commenced in 1961 at the Royal
Sussex County Hospital, Brighton and continued later
at King's College Hospital, London. Since the first
report by Rail, Loo, Lane and Kelly (1957) of the
accidental discovery of persistent fluorescence
attributed to TC in malignant tissue, there have been
a number of reports of the exhibition of this
phenomenon with varying success. The series was
started with the object of verifying this virtually
unique property of the drug, of attaining some skill
in the recognition of the characteristic golden-yellow
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fluorescence, and then of performing a study of the
value of the practical applications of the phenomenon
in diagnosis of malignant disease with particular
reference to gastric carcinomas. Control series of
benign cases with and without TC, and of malignant
cases without TC are also examined.
METHODS
The principle of the exhibition of TC
fluorescence in tumours is that the patient shall be
prepared with TC, an interval be allowed for clearance
of the drug from normal tissues, and the tumour shall
then be examined in a darkened room under an ultra¬
violet lamp.
(a) Preparation of Patient with Tetracycline
If the tumour was on the body surface and
could be illuminated with an ultraviolet lamp, careful
scrutiny for fluorescence was performed before
administration of TC. The dosage and route of admin¬
istration of TC was varied from case to case, partly
in an attempt to ascertain the factors governing the
intensity of fluorescence, but mainly to fit in an
adequate course of TC with an interval of at least
24 hours before the scheduled tine of operation.
The total oral amount of TC administered varied from
2,000 mg. to 10,000 mg. in divided doses spread over
periods ranging from 12 hours to 10 days (see Table 2.)
One patient received a combination of oral TC, 1000 mg.,
and then 8 intramuscular injections of 200 mg. each
over 32 hours as he lapsed into coma. Hone of the
patients had intolerance of the TC capsules even when
receiving 500 mg. 4 hourly or as much as 10 gm. in
total. There were no sensitivity reactions.
The intravenous route was chosen for most of
the large bowel carcinomas as it was thought that the
faeces, being a route of excretion of TC, might
confuse the picture with their own fluorescence* In
some instances where time did not permit an adequate
oral course of the drug, the intravenous route was
chosen. A standard 1000 mg. dose of TC was given in
all these cases by intravenous drip of 200 to 300 ml.
of normal saline. The duration of the intravenous
administration varied from & - 8 hours, but if given
more rapidly was found to cause unpleasant flushing
and a sensation of heat.
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(b) Interval from Tetracycline to Examination
The interval from discontinuing TC to the
time of examination of the pathological material had.
wide variations, especially as in some instances the
neoplastic tissue was not examined until an autopsy-
was performed. However, the shortest period was 25
hours and the longest 48 days, although in some lesions
involving skin or mucosa, serial examinations of the
lesion were made during and after the administration
of TO.
(c) Examination of the Lesions
A total of 40 Dialignant neoplasms were
examined with several different ultraviolet lamps, some
of which were very early models. All were mercury
vapouJ? lamps with an emission as shown in Fig. 1
principally in the 5600 Angstrom band, and were usually
of the type used for wide-spread ultraviolet irradiation
in physiotherapy or dermato logical departments, although
equally good results were obtained with the powerful
beam for more localised treatment. Indeed, this
latter type was tried with its curved quartz rod
applicators, as supplied for therapeutic purposes, to
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study tumours of the nasopharynx and laryruCj but too
much light in the visible part of the spectrum was
produced for any useful results to be obtained. The
most convenient, efficient and portable source used
for the majority of the studies was the Hanau Model
PL 32? with quartz burner S 81, 0.3 kw.
Tumours and other lesions were examined
under three circumstances, operation specimens, autopsy
material and in vivo surface lesions of the skin and
mouth. The majority of the tissues were operation
specimens and were examined fresh and unfixed within
one hour of excision. It is important that the
specimen is not fixed in formaldehyde as this results
in rapid quenching of fluorescence within a few minutes,
although deep frozen specimens or those preserved in
absolute alcohol retain their fluorescence for several
weeks.
The excised operation specimens were examined
within an hour, as with the passage of time there is a
gradual diminution in the intensity of fluorescence
especially if exposed to sunlight. The ultraviolet
lamp was directed away from the observers so that the
beam from the lamp did not directly enter their eyes,
although of course there was some reflection of the
rays. Special protective goggles were tried but
these tended to obscure the observations and as the
period of exposure to reflected rather than to direct
ultraviolet rays was only of the order of 5 to 10
minutes per day no deleterious effects in the form of
conjunctivitis nor visual disturbance were noted.
The examination of the specimens was made in
a darkened room, but complete exclusion of light was
not necessary. Rubber gloves were worn which
protected the hands from ultraviolet bums.
The operation specimen was first dried with
gauze swabs as it was found that blood on the surface
of a tumour obscured the fluorescence, even though
there is a tissue penetration of up to 1 mm. An
independent observer, usually the surgeon or
anaesthetist, checked my visual interpretation of the
fluorescence, and a dried smear of TC was used as a
standard for identification of the characteristic
golden-yellow TC fluorescence.
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After scrutiny of the whole specimen for
fluorescence, the tumour was cut across with scalpel
or scissors so that fresh cut tumour surface could
be examined. Any palpable lymph nodes were cut
across and the gross appearance of any fluorescence
noted.
The autopsy specimens were examined in the
same way as the operation specimens. lesions of the
skin and mouth were examined in vivo with the patient in
a darkened room and the patient was instructed to keep
the eyes closed during the procedure to avoid any
ocular damage from the direct ultraviolet rays.
Colour photography of the fluorescent
specimens using an ultraviolet filter over the camera
lens was attempted at Brighton by the hospital photo¬
grapher with unsuccessful results, although a black-and-
white photograph of a typical fluorescent tumour is
shown later.
RESULTS OP ULTRAVIOIET EXAMINATION
Pour groups of cases were examined for
fluorescence demonstrable by ultraviolet light, as
follows:-
1. Benign lesions NOT prepared with TC.
2. Benign lesions prepared with TC.
3. Malignant tamours NOT prepared with TC.
4-. Malignant tumours prepared with TC.
The case material and results of these groups
are described separately.
1. Benign lesions NOT prepared with TC.
A representative sample of benign lesions
were examined from the operating theatre and autopsy
room and few benign lesions of the skin were examined
in vivo. It was ascertained from the patients
concerned and from the case notes, that neither TC nor
8ny derivative had been prescribed in the previous
three months.
A total of 20 such benign lesions were examined
by the methods described earlier. The clinical details
of these cases are not described as there was no
characteristic golden-yellow fluorescence to be seen in
any case. The lesions scrutinised under ultraviolet
light were all proved to be non-malignant on histological
examination, with the exception of the two patients with
typical varicose ulcers, anc! the two patients with
burns. The lesions examined were as followss-
4 feastopathi®
4 Gastric Ulcers
3 Diverticulitis of Colon
Z Varicose Ulcers
2 Burns
2 leukoplakia of Tongue
1 Uterine Fibroid
1 Cholecystitis
1 Eectal Adenomatous Polyp
Tn these 20 examinations only the dull yellow
autofluorescence of fat and the bluish-grey auto-
fluorescence of other tissues could be seen except for
faint lines of blue-white fluorescence along strands
of connective tissue in breast lesions or on the cut
bowel wall. There was no sign of characteristic
yellow fluorescence of TC.
2, Benign lesions prepared with TC.
Various benign lesions were prepared with
varying doses of TC as detailed in Appendix 1. The
total dose varied from 2,500 to 8,000 mg. TC spread
over 2'6 - 7 days. The interval from TC to examination
of the lesion was from 24 hours to 5 months, although
usually between 24 and 36 hours,
A total of 25 non-malignant lesions were




3 Bronchitis (Bronchial biopsies)
1 Colonic Polyp
1 Crohn's Disease of Ileum
1 Gastritis
1 Varicose Ulcer (examined in vivo)
1 Ganglion of Wrist
1 Keratosis of Tongue (examined in vivo
and biopsy!
1 Lipoma
The details of these cases are shown in
Appendix 1. as very faint golden-yellow fluorescence
was seen in 6 specimens. In 3 benign breast cysts
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there was a faint powdering of yellow fluorescence
on the inside wall of the cyst, perhaps to be explained
by slow exchange of fluid within the cysts. In
another benign tumour of the breast there were weak
yellow fluorescent strands apparently in the inter¬
lobular connective tissue bands. A further patient
had radiotherapy and simultaneous TC in error at another
hospital and was found 3 months later to have chronic
mastopathis with cyst formation and granulation tissue.
This specimen of breast also showed extremely faint
traces of yellow fluorescence. It is stressed that
In all these 5 breast masses the fluorescence was
extremely scanty and faint, being barely visible under
the ultraviolet light. The final case with fairly
strong yellow streaks was in a calcified lymph gland
close to a lesion of Crohn*e disease, although none of
the fleshy glands nearby showed any fluorescence.
Kormsl tissues surrounding malignant lesions
were, of course, examined in the fourth group of cases
and in none was TC fluorescence to be seen.
33
5* Malignant Tumours hOT Prepared with TC
Tumours from patients who had not received
TC or its derivatives at any time in the previous 3
months, as far as could be ascertained from the esse
notes or from questioning the patient or relatives,
were examined with the ultraviolet lamp. In no
instance was there any trace of characteristic TC
fluorescence to be seen in any specimen. A total of
25 such malignant tumours were examined and as the TC
fluorescent results were all negative, details of the
cases will not be given. The tumours examined were
frequently autopsy specimens, although some were
operative specimens, and some were surface tumours
examined in vivo and later given TC, being described
in the next group in detail. The malignant tumours
examined were as follows:-






1 Basal Cell Epithelioma of Skin
1 Chondrosarcoma of Jaw
1 Squamous Carcinoma of Prepuce
1 Hypernephroma
1 Carcinoma of Ovary
Only normal autofluorescence was seen in
all cases*
4* Malignant humours Prepared with TC
Altogether 40 malignant tumours were prepared
with TC, hy the methods which have been given earlier,
in oral doses ranging from 2,000 to 10,000 rag* in total
or by the intravenous route in a dose of 1000 mg* The
interval from administration of the drug to examination
of the tumour was also widely variable from 25 hours to
48 days*
Results
Individual details of dosage of TC, interval,
fluorescence and histology are given in Appendix 2* and
a summary of the dosage of TC, pathology and fluorescence





















































EC 1 8 hr8. IV 6U AdenoCa. Rectum
JM 1 6 hrs. IV 2U AdenoCa. Rectum ?
LS 1 1 hr. IV 66 AdenoCa. Rectum
AM 1 5 hr. IV U8 AdenoCa. Rectum ++♦
TB 1 2 hrs. IV uo AdenoCa. Rectum +-f+
NW 1 1 hr. IV 5 days AdenoCa. Rectum ♦♦
JA U 56 hrs. 0 36 AdenoCa. Rectum ♦♦
EF 1 1 hr. IV U8 AdenoCa. Rectum ♦
LL 5 5 days 0 6 days AdenoCa. Colon ♦+
Tr.B 1 U hrs. IV 5 days AdenoCa. Colon ++
WS 1 U hrs. IV 5 days Ca. Colon ++
VR 1 1 hr. IV 3 days AdenoCa. Colon 0
NG 1 1 hr. IV UO AdenoCa. Caecum ++♦
LC 72 7 days 0 2 days Ca. Breast +++
DD 3 1 day 0 30 Ca. Breast ♦+
DP 5 5 days 0 7 days Ca. Breast ++
AW 2j 20 hrs. 0 2U Ca. Breast +++
IP 3 2U hrs. 0 28 Ca. Breast ++
EB 2 2U hrs. 0 2U Ca. Breast ++
AG 1 \ hr. IV U8 Ca. Breast
LH 2 16 hrs. 0 2U Ca. Breast ++♦
JS 5 5 days 0 UU Ca. Stomach +♦+
PM 5 5 days 0 60 Ca. Stomach ♦
MCu 5 2J days 0 11 days Ca. Stomach 0
HF 5 2J days 0 60 Ca. Stomach ++
JM 6 3 days 0 18 days Ca. Bronchus
AP 2\ 20 hrs. 0 25 Ca. Bronchus ♦
DW 5 2} days 0 30 Ca. Bronchus
JW 5 2\ days 0 30 Ca. Bronchus 0
HC 1 8 hrs. IV 70 Sq. Ca. Anus 4-f
WL 3 2k hrs. 0 30 Sq. Ca. Prepuce ♦♦♦
DT 1 1 hr. IV 28 Sq. Ca. Skin
'
AP 10 10 days 0 U8 days Basal Ca. Skin
ME 5 5 days 0 53 Basal Ca. Skin ♦♦
JB 1 U hrs. IV U8 Malig. Melanoma Glands 0
PH 8 & days 0 8 days Ca. Renal Pelvis
MCI 7 7 days 0 U8 AdenoCa. Kidney
HW 2 16 hrs. 0 30 Salivary Ca. ♦♦
EP 2.6 UO hrs. 0 & IM 2U Salivary Ca. ♦♦♦
SC 7i 7 days 0 36 Chondro Sa. ♦♦
(blue)
Individual case details given in Appendix 2,











In discussion the self-explanatory terms,
"brilliant", "moderate" and "weak" will be applied to
the overall impression of the tumour fluorescence
rather than to individual areas of variable intensity.
Where the term "dubious" is applied any possible
fluorescence was so weak as to be difficult to identify
with certainty. Such "dubious" cases of fluorescence
should be included with the negative results, as there
is uncertainty regarding the appearances, and they
certainly cannot be regarded as exhibiting definite
characteristic golden-yellow colour.
Out of the 40 malignant tumours examined,
there were 4 which showed only autofluorescence and no
characteristic golden-yellow colour under ultraviolet
light. These 4 cases comprised an adenocarcinoma of
rectum, secondary deposits in lymph nodes from a
malignant melanoma, an adenocarcinoma of stomach, and
a fragment from a biopsy of an oat-cell carcinoma of
bronchus. In addition, there was one "dubious"
fluorescent result in another adenocarcinoma of rectum,
which should be grouped with the negative fluorescent
results.
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Of the remaining 35 tumours examined, 15 gave
an overall impression of "brilliant fluorescence", 17
of "moderate fluorescence", although in some of these
there were brilliant flecks, and 3 were "weak" although
definite yellow fluorescence was visible.
Relation of Fluorescence to Tumour Type
A selection of malignant tumours were examined
from different organs, after varying doses of TC, by
different routes and with different intervals between
the administration of the drug and examination of the
tumours.
The largest group was of 13 adenocarcinomas of
the large bowel, 8 being of the rectum and the remainder
of the colon, but as there is no real histological
distinction between them, they will be considered together.
The range of intensity of fluorescence was mainly
brilliant or moderate, although one showed "weak"
fluorescence, one " dubious" and one no yellow fluoresc¬
ence at all. In this last case there were some intense
blue-white fluorescent flecks in the tumour. There
seemed to be no relationship between the degree of
differentiation and the intensity of the fluorescence,
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for the "weak" fluorescence was In a well-differentiated
carcinoma, the "dubious" in a poorly-differentiated
carcinoma and the carcinoma showing no yellow
fluorescence at all was also well differentiated,
lymph nodes ?/ere felt to be enlarged in association with
6 large bowel tumours. ?7hen sectioned these glands
showed varying fluorescence and in them there was
histological confirmation of the spread of the disease.
All S carcinomas of the breast showed moderate
or brilliant characteristic yellow colour on examination
with the ultraviolet light. Again the degree of
histological differentiation did not seem to influence
the fluorescence.
Similarly the histological differentiation did
not seem to be a factor in determining the intensity of
fluorescence of the 4 gastric carcinomas, two of which
were "brilliant", one "moderate", one "weak" and in one
no characteristic fluorescence was visible at all.
Of the 4 carcinomas of bronchus, one was
squamous and 5 oat-cell in type. One of the oat-cell
carcinomas did not show any fluorescence when a fragment
of a bronchial biopsy was smeared on a glass slide,
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but it is possible that this was due to sampling
error rather than a failure of the tumour to take up
TC. The remaining tumours exhibited variable but
definite fluorescence#
Of the remaining 11 assorted tumours, only-
one failed to show any fluorescence. This was in
lymph gland secondaries from a malignant melanoma.
Five were squamous or basal cell carcinomas of skin,
two were renal carcinomas, two salivary-gland carcinomas,
and one was a chondrosarcoma of jaw. Many of these were
examined in situ and all showed moderate or intense
yellow fluorescence. The details of the examinations
may be seen in Appendix 2.
Relation of Fluorescence to TC Dosage Regimes
The total amount of TC administered orally
ranged from 2 to 10 gms, in divided doses over periods
varying from 16 hours to 10 days, Keither the total
dose nor the duration of the course of the drug seemed
to determine the intensity of fluorescence. Both of
the patients who received oral TC, hut who tumours did
not fluoresce, had received a total of 5 gffi, TC, an
amount which proved quite adequate in preparing many of
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those tumours which showed good flucreseenee.
The intravenous route was chosen for admini¬
stration of TC in 15 patients, and in all of them a
standard dose of 1.0 gm. was given. The time over
which TC was given by intravenous drip varied from to
8 hours. The two cases with dubious or absent
fluorescence in the large bowel carcinomas received the
drug over 6 hours and 1 hour respectively, and the
patient with melanomatous secondary deposits over 4
hours.
There was no appreciable difference in the
intensity of fluorescence induced by 1.0 gm. given by
intravenous injection and by the larger doses of TC
given by mouth. The lowest oral dose administered was
2 gm. over 24 hours and this gave moderately intense
fluorescence. If time permits, larger oral doses
might prove more efficient in inducing maximum
fluorescence, but we have no evidence to support this.
As the intravenous administration of 1.0 gm. can produce
brilliant fluorescence it may well be that the intensity
is related to the blood level achieved rather than the
total amount given.
Relation of Fluorescence to the Interval from TC to
Examination/
There was a wide variation in the interval
between stopping the administration of TC and examina¬
tion of the tumour with the ultraviolet light. The
shortest interval was 24 hours and the longest 48 days.
This latter patient had a rodent ulcer of the leg which
was not fluorescent before TC, She was given a 10-day
therapeutic course of the drug, during which time the
ulcer was seen to be moderately fluorescent, and was
then discharged home to attend for outpatient radio¬
therapy. She was admitted 48 days later for surgical
treatment, and the moderate fluorescence was much the
same as it had been when she was actually receiving the
drug, indicating no appreciable dimming of intensity
with the passage of time.
Careful scrutiny of the intensity of
fluorescence in relation to the period from TC to
ultraviolet examination does not reveal any significant
diminution of intensity with the passage of time. The
shortest interval necessary for clearance of TC from
non-malignant tissues has not been determined, but it
would seem likely on theoretical grounds that it should
not be shorter than 24 hours.
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SUMMARY OF FLUORESCENT STUDIES IN BENIGN AND MALIGNANT
TISSUES.
Of 40 malignant tumours examined after TC,
35 tumours were shown to exhibit characteristic
golden-yellow fluorescence when exposed to ultraviolet
light. There was wide variation in the intensity
and uniformity of the fluorescence.
No relationship could be discovered between
the intensity of fluorescence and the site or type of
malignant tumour or its degree of histological
differentiation.
There was no apparent relationship between
the amount of TC exhibited and the intensity of
fluorescence, but the suggestion is made that it is
dependent on peak blood levsls achieved. With the
passage of time the intensity of fluorescence in
malignant tumours did not show appreciable diminution,
and could be demonstrated for as long as 48 days.
The maximum duration was not determined.
There was no apparent reason why 5 tumours
(12.5%) should not fluoresce and it is suggested that
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this lack of uptake of TC is due to individual
idiosyncrasy, the cause of which was not shown.
In 20 benign lesions not prepared with TC
there was no characteristic fluorescence.
In 25 benign lesions prepared with TC,
faint fluorescence was seen on the inside of 3 benign
cyst walls and as faint flecks in 2 benign cases of
raastopathia. One calcified lymph node showed
fluorescence.
In 25 malignant tumours without TC, there





In 1957» the accidental discovery of TC
uptake by malignant tissue was made by Rail, Loo,
Lane & Kelly (1957). They were studying the
pharmacological properties of a riboflavins antagonist,
U6538, by examining tissues under ultraviolet light
from a patient with malignant disease who had been
given the antagonist. They found fluorescence in
portions of the tumour, a metastatic breast carcinoma.
When examining malignant tissue from other patients
they found that the fluorescence was not the result of
their riboflavins antagonist, and the medications
received by those patients whose tumours fluoresced
under ultraviolet light were reviewed. This suggested
that TC, which also shows yellow fluorescence in
solution, might be the cause of the yellow fluorescence
in tumours. They then pursued the observation of this
phenomenon by giving TC to mice or rats by infection,
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intramuscularly, intra peritonea lly or subcutaneously,
for 2-5 days. They demonstrated TC fluorescence
under ultraviolet light in rodents with various
tumours, as follows:-
Tumours showing Fluorescence






























- - - -
Tumours not showing Fluorescence.
lymphoma 1, Leukaemia 2416, Leukaemia 1210,
Harding Rassey Melanoma, Cloudman Melanoma S91 in mice.
Rail et al. (1957) in these studies noted
that after an intra-peritonea 1 injection of 2mg. TC to
mice, for the first 6 hours the drug appeared in most
areas except the brain. Tumour tissue, the liver,
parts of the intestines, and bony tissue retained the
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fluorescence for 24 hours, but thereafter the
characteristic golden-yellow TC fluorescence was seen
only in tumour, bone and teeth where it persisted,
essentially undiminished until death of the animal in
10 to 20 days. The fluorescence in the tumours was
distributed diffusely in the more peripheral areas and
was not apparent in the grossly haemorrhogic or
necrotic zones.
The same workers demonstrated that 1 ag. TC
per mouse, in single or individual doses, produced
fluorescence in half the animals with sarcoma 37, up
to 4 mg. in most of their animals, and 3 mg. or over in
all these mice. Taking the mouse weight as 20 gas. and
a dose of 2 mg., with extrapolation to a 70 Kg. man,
this would be equivalent to a total dose of 7,000 mg.♦
the usual therapeutic course of TC given over 1 week.
They also demonstrated that all three of the
TC antibiotics then in wide usage - TC, CTC and OTC -
were qualitatively similar In causing the fluorescence
in mouse sarcomas.
Since these initial observations a number of
reports (Table 3) confirm the phenomenon of TC uptake
After 46
TABLE 3.
GROSS FLUORESCENCE OF TUMOURS AFTER TETRACYCLINi: DRUGS - SURVEY OF LITERATURE
Authors Year Tumours showing Fluorescence Tumours etc. IJOT showing Notes
yellow fluorescence












2 Squamous Carcinoma, Cervix
1 Adenocarcinoma, Kidney
1 Thymoma, Thymus
1 Squamous Carcinoma, Larynx
1 Adenocarcinoma, Pancreas
2 Metastatic Carcinoma, Bone
1 Adenocarcinoma, Thyroid
3 Osteogenic Sarcoma, Bone
1 Paget*s Disease, Bone
1 Ewing's Tumour, Bone
Nil More than 1000 normal tissues showed
blue autofluorescence. More than 200
tumours without tetracycline showed
only blue autofluorescence.
Vassar i960 3 Squamous Carcinoma, Cervix Nil
et al 1 Squamous Carcinoma, Skin - for 3 weeks
1 Squamous Carcinoma, Penis
1 Chorionepithelioma Metastasis,
Testis to Skin - for 3 weeks
1 Adenocarcinoma, Pancreas - for U weeks
2 Undifferentiated Carcinoma, Bronchus -
for 8 and lU weeks respectively
Philins I960 8 Adenocarcinoma, Colon 2 Adenocarcinoma, Colon )
et al 2 Adenocarcinoma, Rectum 2 Adenocarcinoma, Rectum ) Elue
3 Adenocarcinoma, Breast 1 Adenocarcinoma, Breast ) fluor-
2 Adenocarcinoma, Stomach 1 Osteogenic sarcoma - ) escence
2 Reticulum cell Sarcoma, Stomach Metastatic to chest wall)
1 Hepatoma, Liver 1 Squamous Carcinoma f'etast-) Dull
1 Squamous Carcinoma, Lip asis, site unknown ) grey
1 Squamous Carcinoma, Tonsil 2 Transitional Carcinoma ) auto-
1 Squamous Carcinoma, Mouth (metastatic) Kidney ) fluor-
1 Epidermoid Carcinoma, Parotid 3 Adenocarcinoma, Stomach ) escence
1 Squamous Carcinoma, Tongue
Fibroadenomas, cystic disease and
ductal hyperplasia of breast,
thyroid adenomas, mixed parotid
tumour, duodenal and gastric ulcers,
benign rectal polyps, diverticulitis,
villous adenoma of rectum, haemorrh¬
oids, numerous fresh normal tissues
from tetracycline-prepared patients,
and carcinomas from patients who had
not had TC
ALL showed only autofluorescence
Bailey &
Levin






One of the Osteogenic Sarcomas had
much calcification and fluorescence,
but the other 2 of the fibrous type
had only little fluorescence
Prout
et al
1962 3 Prostatic Carcinoma bone metastases Although primary tumour & soft tissue
metastases showed no fluorescence
Carter
et al
1962 7 Carcinoma, Stomach
12 Carcinoma, Colon
5 Carcinoma, Breast
2 Benign Tumours, Bone
3 Carcinoma, Colon
U Carcinoma, Breast
6 Benign Tumours., not bone
Milch
et al
1961 1 Reticulum-cell Sarcoma )
1 Osteogenic Sarcoma )
1 Malignant Giant Cell Tumour) - of bone
5 Metastatic Tumours )
H Osteochondromas
2 Chondrosarcomas
-fluorescent only at cartilaginous
base.
-one no fluorescence and in the other
Fluorescence wherever \ only close to
evidence of matrix \ the invading
calcification with \margin
Alizarin red S posi¬
tive areas
Takayama 196U 8 Carcinoma, Breast 3 Mastopathy Extremely vivid yellow of "panniculus
2 Carcinoma, Stomach 1 Chronic Interstitial Mastitis adiposus" of breast (different from
j* Benign Tumours TC fluorescence)
and retention by malignant tumours as demonstrated by
characteristic fluorescence under ultraviolet light.
McLeay (1958) was the first to make clinical
observations of this fluorescence. He examined
surgical specimens of normal tissues from over 1,000
patients without cancer and from 42 patients with cancer,
none of whom had received TC, and was able only to
demonstrate autofluorescence on examination of the
tissue with an ultraviolet light source of 3660 Angstrom
units. An additional control group was of 11 patients
who had received TC but had benign lesions, and they
similarly showed only autofluorescence. However 11
patients with malignant disease prepared with TC,
allowed an interval of 12 hours in which to clear TC
from normal tissues, and from whom the surgical specimen
was then examined, showed in all cases a characteristic
yellow fluorescence in the tumours.
By 1962, Mcleay and Walske had extended this
original series of observations to include a control
group of more than 200 carcinomatous cases who had not
received TC and showed only blue sutofluorescence. He
had increased his group of carcinomas to 37» all of which
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exhibited golden-yellow fluorescence under ultraviolet
light# Using biological assay they found a TC
concentration of 10 per gin. in good fluorescing
tumours ranging down to 1*0 jxg. per gm# in poorer
fluorescing tumours# On preliminary ultraviolet
microscopy they thought that the fluorescence was
situated within the tumour cell#
Yasser et al. (I960) challenged the specificity
of the fluorescence. Whilst in all 9 cases of carcinoma
pre-treated with TC they were able to demonstrate
typical bright yellow fluorescence, they comment on the
difficulties of the inexperienced observer with the auto-
fluorescence of adipose tissue (pale yellow), and the
microscopic autofluorescence of lipo-fuscin (brilliant
yellow orange), porphyrins (red), and histocytes contain¬
ing granules of lipoproteins. Their microscopic studies
showed fluorescence invariably confined to macrophages
and tissue debris in the tumour stroma, and stress that
in no case was a malignant cell seen to fluoresce# They
point out that in patients with non-specific skin ulcers
fluorescence may persist up to 72 hours, compared with
periods of up to 14 weeks fluorescence after TC in
malignant tissue.
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In the same year, Phillips et al* (I960)
also found only sutofluorescence in benign tumours or
inflammatory diseases, but in 12 out of 35 malignant
tumours the characteristic yellow fluorescence was not
seen as it was in the other 23 malignant cases. In
half of these apparently negative cases a bluish
fluorescence was seen which the authors think might be
a very weak positive result os it was so distinct from
surrounding autofluorescence. They thought that their
negative or equivocal results might be due to an
inadequate dose of TC being administered in those cases,
and certainly their results tend to indicate that in
part the dose of TC administered influences the intensity
of yellow fluorescence. Extraction of TC from tumour
tissue was performed with a fair co-relation between
the intensity of fluorescence and the amount of drug
obtained - up to 7,6 mg./g®. tumour tissue, a much higher
concentration than that found by Mcleay & iPalske (1962).
Their impression was that the highly anaplastic tumours
had a greater avidity for TC than the well-differentiated.
Carter et al. (1962) found TC fluorescence in
24 out of 31 malignant tumours after intravenous TC
preparation of the patients, and the histological
studies suggested the fluorescence was not within
the tumour cells. Only 2 benign bone tumours showed
fluorescence.
The preceding studies have included mainly
alimentary and breast cancers, but bone tumours have
been shown by McLeay et al. (I960) and Bailey & levin
(1961, 1963) to exhibit the same phenomenon (see Table
3.) and it is of interest to note that the second
authors felt that the fluorescence was related to the
presence of active calcification in the tumours or at
sites of reactive bone formation. Their two negative
results occurred in a fibro-sarcoma and a highly
anaplastic fibrous tissue sarcoma, neither of which
showed any evidence of calcification.
Milch et al. (1961) studied 10 malignant bone
tumours of which 5 were metastatic carcinomas and
demonstrated TC-induced fluorescence in them all. It
is of importance however that in addition he demonstrated
fluorescence in 4 benign osteochondromas. His
explanation, supported by ultraviolet microscopy, was
that the localisation of fluorescence occurred only in
those areas in which matrix calcification was observed,
the same areas where Alizarin red-S staining occurred
and where there were distinctive morphological features
in the matrix on phase, dark field and polarized light
studies.
However, Ackerman and McFee (1963) reporting
their studies on an unspecified number of fresh autopsy
specimens where the patients had received therapeutic
courses of a TC compound at varying intervals before
death, stated that the deposition of TC in malignant
tissue was "erratic and ^independable"• The total
dose of the drug was not stated but they could find no
obvious pattern for predicting the presence or lack of
fluorescence in relation to histology, dose or route of
administration. Unlike previous workers, they found
that fluorescence was often associated with necrotic
elements of malignant tissue. In addition they
demonstrated bright areas of yellow fluorescence in
non-cancerous tissue. Apart from the well-recognised
retention by bone, fluorescence was shown in 3
specimens of pancreatic fat necrosis, a necrotic area
of diverticulitis, pyonephrosis, a gall stone and
"several other necrotic areas" in autopsy tissues*
It should "be noted however that in their studies the
interval from discontinuing the drug to death was
"at least 16 hours" so it is possible that in sites
of poor excretion and poor viability a delayed
clearing of TC was being observed* Again they note
the presence of TC deposits on ultraviolet microscopy
in necrotic tissue and stroma rather than within
malignant cells* In studies on rats and hamsters
using transplanted Novikoff hepatomas and amelanotic
melanomas, no fluorescence was demonstrated, perhaps
due to tumour type differences*
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Discussion
Since the original observations of Rail
et al. (1957), it has been shown by McLeay (1956),
Vassar et al. (I960), McLeay & Walske (1962) and
T&kayama et al. (1964) that in their experience all
malignant tumours except leukaemias fluoresce a
golden-yellow colour after preparation of the patient
with TC (see Table 3«) total number of soft tissue
malignant tumours examined by these authors is 56.
Large numbers of normal tissue and benign lesions with
and without TC preparation, end malignant tumours
without TC, showed only autofluorescence. Vassar et al.
(I960) commented on the difficulties of interpretation
of autofluorescence by the inexperienced observer.
However, Phillips et al. (I960) found only
two-thirds of their malignant tumours fluoresced bright
yellow. Of their remaining 12 malignant cases, half
showed a definite blue fluorescence which they thought
was a weak TC result as it was so distinct from grey
or dull yellow autofluorescence and as they tended to
use rather low dosage regimes. Autofluorescence was
seen in 21$ of their malignant tumours, in all of their
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benign cases prepared with TC, and in all malignant
tumours not prepared with TC. It is of interest to
note that in my own series, one rectal carcinoma
showed this same blue fluorescence.
Similar experience was obtained by Carter
et al. (1962) with 77% of their malignant tumours
showing yellow fluorescence after intravenous TC
preparation. This percentage compares with 87% yellow
fluorescence in my own series of soft tissue malignancy.
Results with malignant bone tumours show a
rather different pattern. It would appear from the
results of Bailey & Levin (1961), and Milch et al. (1961)
that in bone sarcomas fluorescence is only to be found
if there is evidence of matrix calcification.
Secondary carcinomatous deposits in bone show fluorescence,
but Erout et al. (1962) observed that in the case of
prostatic carcinomas the primary tumour and soft tissue
metastases did not fluoresce. It would also appear
that benign bone tumours may fluoresce, especially at
the bases where calcification may be occurring. In
my own series only one malignant bone tumour, a chondro¬
sarcoma of jaw was seen and showed persistent
fluorescence•
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The ma,jor attack on the specificity of TC
fluorescence was levelled by Ackerman & McFee (1963),
but as their article was unsupported by specific
numbers and the interval from TC to examination in
some cases was as short as 16 hours, it is difficult
to assess the importance of their criticisms.
Certainly there may be persistence of TC fluorescence
in necrotic and calcifying tissues, as will be
discussed later in the sections on the nature of the
fluorophore in sites other than malignant tissue, but
this does not invalidate the tumour results. Indeed,
in benign lesions in the present series, fluorescence
could be found in minute amounts in cyst walls and
tissue of some benign breast tumours, possibly due to
the calcium content of milk, but it is emphasised that
there was no comparison with the amount seen in
malignant tumours. Only one calcified gland showed a
moderate amount of yellow fluorescence.
The relationship between degree of differentia¬
tion and intensity of fluorescence has been discussed by
several authors. McLea.y et al. (1958) suggests that
carcinomas with the most rapid growth showed most
fluorescence, and Phillips et el. (I960) had the same
impression. In my own series the differentiation of
a tumour did not seem to determine its fluorescence.
The limit of duration of TC fluorescence
has not been analysed but in my own series it persisted
for 7 weeks in one patient and Vassar et a 1. (I960)
observed fluorescence 14- weeks after administration
of TC.
With low dosage schedules of TC there may be
an increasing deposition of TC in malignant tumours
with increasing dose (Phillips et al.t I960). It is
suggested that, provided adequate blood levels are
achieved, either by 5 gm. orally in divided doses or
by 1.0 gm. intravenously, there is no direct correlation
of fluorescent intensity with total dose of TC. No
cause has been demonstrated by any workers as to why
some malignant tumours do not fluoresce or fluoresce
less intensely than others.
The Fluorophore in Malignant Tissue
Whereas fluorescein was observed by Moore
(194-7, 1948. ) to have a tendency to localise
temporarily in tumour tissue when administered parentally,
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TC compounds appear not only to localise but also to
concentrate and remain bound to malignant tissue for
prolonged periods* The mode of deposition of the TC
and the nature of the fluorophore in tumours has
stimulated much research for this remarkable property
of prolonged sequestration of drug by tumour tissue
has obvious therapeutic implications as yet unrealised.
The major problem to be discussed in this
section is the reason for localisation of TC in tumours
as opposed to most other normal tissues (with the
exception of bone and teeth) for there is no doubt that
preferential concentration of TC within the malignant
tumour occurs whilst TC is being administered.
Although it has been shown that normal soft tissues
will fluoresce whilst therapeutic blood levels ofctain,
the tumour, even at that time, shows more intense
fluorescence than surrounding normal tissue. Secondly,
the reason for the prolonged retention of TC fluorescence
in the tumour is of importance particularly as it may
shed some light on the differences in metabolism of
malignant disease as compared with physiological
tissue•
Investigations into the nature of the
fluorophore were started by the original observers of
the phenomenon using CAF( mice with Sarcoma S-57
(Loo, et al. 1957)• After preparation with intra¬
peritoneal TC, they obtained tumour tissue which they
homogenized in water. The homogenate was dialyzed
against dilute hydrochloric acid (0.1 N), as TC remains
stable for at least 4 hours in this concentration of
acid. When the pH of the filtered dialyzate was
adjusted to above 7 the fluorophore came down as a
flocculent precipitate which flurosced bright greenish
yellow under ultraviolet light. With a dialyzate
similarly prepared from tumour tissue ef control mice
which had received no TC, a similar flocculent
precipitate was obtained. This was however not
fluroscent. In both cases the precipitates gave
positive ninhydrin and biuret tests, thus suggesting
their peptide nature. A more concentrated solution
of fluorophore was prepared by these workers by centri-
fugation of the dialyzate. After saturation of
alkaline dialyzate with salt the fluorophore could be
partially extracted into butanol. Examination of the
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ultraviolet absorption spectrum of this extract compared
with the spectrum of TC itself in butanol revealed that
the excitation peak at $67 mp. of the parent compound
had undergone a shift of 15 rap. to 382 mp., the blank
itself obtained from control rats without TC showing
no absorption at this range. Such a bathochromic
shift could be ascribed to the formation of a complex
between TC and peptide in tumour tissue.
Paper electrophoresis showed the migration
rate of the fluorophore at pH 8.6 differed quite
noticeably from that of TC and similarly, paper
chromatography showed quite different values. More¬
over in weak acid neither the fluorcphore nor the
control non-fluorescent precipitate displayed any new
absorption bands or any shift of existing bands. Loo
and his associates therefore concluded that the complex
formed between TC and the peptide must be a loose one
with ready dissociation in acid. Assuming that the
peptide of the control and that of the TC-treated
tumour exhibit identical absorption patterns, they were
able to calculate the absorbance owing to the prosthetic
group and this was found to be exactly identical with
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the spectrum of TC at that concentration and pH.
The identification of this prosthetic group
of the fluorophore as being TC is supported by the
evidence that after exposing to normal hydrochloric
acid for 1 hour, the spectrum of the prosthetic group
can be shown to be the same as that of anhydrotetra-
cycline, as would be expeeted?for the effect of a
stroDg acid is to dehydrate the TC molecule to this
compound with rapidity. Thus these authors, without
actually isolating the prosthetic group, had demonstrated
that the fluorophore in the tumour from a IC-treated
mouse was most likely to be a complex formed of the
parent compound and a peptide.
Kohn (1961b) also of the National Cancer
Institute, Bethesda, quotes unpublished experiments of
Lane, Titus ft. Loo indicating that the TC complex in
tumours is dissociated by EDTA. His experiments were
designed to test the hypothesis that metal ions may act
in the systems of TC fixation in tumours and bone by
simultaneously binding TC 3Dd suitable macromolecular
sites. Higuchi & Eolton (1959) found that
deoxyribonucleic acid (DNA) formed a very firm complex
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with TC. Kohn therefore studied the interaction of
TC with DNA and with serum albumin in the presence and
absence of divalent cations, using the technique of
equilibrium dialysis. He found that little or no TC
became bound to DHA in the absence of divalent metal
ions (zinc, calcium, manganese, magnesium) but that
binding did occur in their presence. In the case of
serum albumin, TC binding occurred in the presence of
zinc but not calcium. TC chelates of calcium and
zinc showed fluorescence which was enhanced markedly
by the presence of DHA and albumin. As a result of
his fluorescent experiments he felt he had shown
support for the picture of a bond between JDflA (or
albumin) and the metal component of the TC chelate.
That there is a protein-binding of the drug
was confirmed by Wozniak (I960) who studied the binding
of TC drugs with dog and human plasma by dialysis
equilibrium technique under physiological conditions of
temperature and pH. The percentage bound was about
32J* for TC, 513* for DMTC and 64^ for CTC. A study with
TC gave no difference in binding at 37 or 4°C. but
binding increased with increasing alkalinity from pH 6.7,
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when 30% was bound, to pH 8.1 when nearly 60% was
bound.
Kachado et al. (1964) studied the local¬
isation of TC in transplantable sarconaa-37 tumours in
mice utilising the radioactivity and fluorescence of
tritiated TC as measures of concentration. The
tritiated TC used in this study differed from the parent
molecule only by the substitution of tritium for hydrogen
iri the 7 - position. This study on large groups of
animals showed three different patterns of organ
fluorescence. Organs such as the liver and heart
presented a diffuse homogeneous yellow fluorescence on
the cut surface appearing within the first 24 hours of
injection of the drug and not present to significant
degree after 48 hours. Bone fluorescence was also
homogeneous, appeared within 24 hours and persisted for
the duration of the experiment (8 days). Tumour
fluorescence was not homogeneous, appeared within 24
hours and was distributed in well-demarcated areas
differing in shape and size, and located both on the
surface and within the tumour. Fluorescence was
related to tumour age, i.e. the duration from
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implantation to sacrifice. Forty seven per cent of
the 10-da,y old tumours and 100% of the 13-day or older
tumours were fluorescent. None of the tumours of less
than 10 days of age showed the characteristic
localised fluorescence. Similar results were obtained
with the more slowly growing Ehrlich's solid tumour in
C57 mice.
By fluorescent microscopy, against the faint
greenish-blue autofluorescence contrasted the spotty
bright .yellow to gold fluorescence throughout the
tumour cell cytoplasm, a finding in agreement with the
earlier observations of McLeay & Walske (1962) in human
tumours. Ho fluorescence was seen in the intersticial
spaces and the nuclei produced a negative image. The
fluorescent spots all corresponded to groups of tumour
cells in more or less advanced states of degeneration.
The cytoplasm of these cells was always eosinophilic and
most of the nuclei were small and hyperchromatic. No
macrophages were seen in the fluorescent areas in contra¬
distinction to the report of Vassar et al. (I960) who
reported the localisation of TO in tumours to be in the
associated macrophages. From the fluorescent studies
it seems that TC is retained in greater quantities in
those areas of the tumour that are dead or dying.
The studies using tritium-labelled TC confirm this
finding, by showing that the apparent concentration
is not an artifact due to selective quenching of the
fluorescence.
The greatest intensity of fluorescence was
seen in the transition zone between the obviously
viable and the obviously necrotic fragmented cells.
In the centre of a frankly necrotic area the absence
of fluorescence, as noted by Rail et al. (1957) and
Phillips et al, (I960), could be explained by the lack
of blood supply to provide a route of entry for the TC,
One of the earliest signs of cell injury is the loss of
selective membrane permeability which might lead to a
passive assimilation of free or protein-bound TC,
Majno et al, (I960) in a critical series of
experiments on the time intervals of cellular death and
necrosis comments on the denaturing of proteins giving
rise to increased autofluorescence of liver cells
developing between 15 and 30 minutes after sudden
complete ischaemia. It may be that the TC uptake by
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necrosing tumour cells is related to this protein
denaturation in the cytoplasm.
Shear (1955) reviewing the earlier literature
of tumours concluded that the non-necrotic areas of
degenerating tumours contained relatively little
calcium whereas the necrotic areas contained extensive
amounts of calcium. A later study by Suntzeff &
Carruthers (1944) revealed a linear relationship
between increasing necrosis and increasing calcium
content up to 0.077 mg* per 100 mg. in epidermal
tumours of mice, whereas the calcium content of the
completely viable tumour, 0.009 ®g» per 100 mg., was
quite depressed relative to the tissue of origin,
0.044 mg. per 100 mg. epidermis. Thus a body of
circumstantial evidence lends some credence to the
hypothesis that the predilection of TC for devitalised
tumour tissue exists by virtue of its ability to
chelate calcium.
When Machado et al. (1964) administered
Alizarin red-S, an acid dye which chelates calcium,
systemically to mice bearing S-37 tumours, the dye was
visible grossly after 36 hours only in the necrotic
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areas of the tumours and in the hones. However,
since closely related dyes may localise either in the
necrotic (trypan red) or in the viable (trypan blue)
areas of tumours as shown by huran-Reynals (1939)» this
localisation of Alizarin red-S cannot necessarily be
attributed to its known calcium-chelating propensity,
although it seems likely.
The concept of calclum-chelation being a major
mechanism for sequestration in tumours has biochemical
support in the work of Albert (1953)» Albert & Rees (1956)
who demonstrated in vitro a high avidity of the TC's for
calcium. In histological studies by Malek & Kolc (I960)
of spontaneous mammary tumours in bitches, differing
degrees of TC-indueed fluorescent intensity seemed to
be related to the degree of calcification, although the
exact site in relation to the malignant cell was not
described.
Moreover, a detailed study by Riley (1963)
of the fluorophore in a transplanted human tumour in
the cheek pouch of cortisone-treated Syrian hamsters
showed TC-induced fluorescent islands which tended to
enlarge, never decreased and were not islands of
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necrosis, inflammation or infection. Ultraviolet
microscopy revealed the golden yellow fluorescence of
TC to be present within tumour cells. The presence of
calcium, as demonstrated by the von Kossa stain and by
microradiography could be well correlated with the
presence of fluorescence. Calcium was always present
in those areas of the tumour which fluoresced. When
sections were treated with EDTA to remove calcium,
fluorescence could not be demonstrated. It is
emphasised that gross calcification of the tumour was
not present. There was not calcification of the
stromal connective tissue elements of the tumour but
rather microcaIcification within tumour cells.
In contrast Yabe et al. (1964) did not find
selective, persistent TC-induced fluorescence in gastric
adenocarcinomas transplanted into the subcutaneous
tissues of C57BL mice. The tumour was descended from
a gastric adenocarcinoma induced in mice by injections
of 20-methylcholanthrene into the stomach wall. The
reason for failure of selective localisation in this
tumour is not clear, but it could be simply an idiosyncracy
of that particular tumour, or it might conceivably be
related to "tumour age", as the authors simply say
that they exhibited TC when the tumour was "two or
three weeks old".
However there is evidence for other tissue
components as well as calcium, peptides and proteins
having a capacity for binding TC. There is an affinity
for serum beta-lipoproteins which is so pronounced in
the presence of calcium ions that the reaction has been
proposed by Lacko et al. (1959) as method for the quant¬
itative precipitation of this fraction. This particular
affinity of TC exists also for the beta-lipoprotelns of
liver mitochondria (Pamukco et al. (1963), although
Du Buy & Showacre (1961) feel that this localisation
plays an insignificant role in the phenomenon of macro¬
scopic tissue fluorescence. Similarly, although it has
been shown in the beautiful autoradiographic studies by
Andre (1956) using tritium-labelled TC that there is a
significant amount of TC in the cell nucleus, there is
no evidence for tumour-cell nuclear fluorescence.
Since in addition to TC several chemical
species of grossly unrelated structure, such as hsemato-
porphyrins (Rassmussen-Taxdal et al. 1955) radloiodine
(Clode et al., 1961) and dyes such as trypan red
(■Duran-Reynals, 1939) and fluorescein (Moore, 1947),
appear to localise preferentially in tumour tissue, a
single basic physiological defect or physio-chemical
interaction might underlie the behaviour of all of
them. There is probably an element of increased
capillary permeability involved in the less viable
areas of tumours (Duran-Eeyn&ls, 1939) predisposing
to leakage of various native and foreign materials
into these areas. However, there undoubtedly exists
some sort of mechanism for binding or sequestering
these substances from the general circulation. In
the case of TC it appears most likely that chelation
with calcium is the most important factor in the
remarkably prolonged retention of this fluorescent




The localisation of TC drugs in bone is of
relevance to their localisation in tumours in so far
as the mechanism for deposition may be similar and
the exhibition of the phenomenon is by the same
observation of a characteristic golden-yellow
fluorescence when the material is exposed to ultra¬
violet light. It therefore seems desirable that an
outline should be given of work in the field of
TC-induced bone fluorescence.
Normal Bone
Following the initial observation of tumour
fluorescence by Rail et al. (1957) the same group of
workers, Milch, Rail and Tobie (1957* 1958) report
their studies on bone from various experimental
animals. After parenteral TC 5 to 200 mg./Kilo,
they demonstrated fluorescence under ultraviolet light
lasting in soft tissues for 30 minutes to 6 hours.
By 12 hours the fluorescence was confined to bone and
teeth. Brain at no stag© showed fluorescence and
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after 12 hours it could be demonstrated in an
occasional specimen of liver. When once the fluoro-
phore was deposited in bone it was not displaced over
a period of 10 weeks observation of the experimental
animals. It was observed that young bone showed the
most Intense fluorescence, whereas old bone tended to
give a less intense creamy colour. Articular and
epiphyseal cartilage showed under ultraviolet light,
both grossly and with ultraviolet microscopy, a deep
blue or bluish-grey autofluorescence which contrasted
vividly with the golden-yellow fluorescence of new bone
proliferation. Periosteal and endosteal surfaces
were more brilliant in young animals than in old.
They also showed that fluorescence in bone could be
demonstrated within 30 seconds of exhibition of the
drug, even when doses as low as 0.3 mg./Kilo were used.
It was noted that TC was deposited in the same
sites as Alizarin as reported by Cameron (1930), and in
4.5
the same sites as Radio-calcium (Calcium y) as reported
by Arnold, Jee & Johnson (1956). There is a structural
similarity of TC with its four 6-membered rings and
Alizarin with its three similar rings. It would seem
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possible that both may bind to calcium by the sea®, or
similar, mechanisms♦
Thus the distribution of tetracycline in bone
is not homogeneous and is determined by the rebuilding
process and free surface chemistry of the bone mineral.
Sites of new bone formation show the highest
concentrations but old bone is also able to bind TC
in low concentrations owing to calcium ions on the
surface of the apatite. The amount of TC deposited
per gramme of bone depends on the number of reactive
cylinders or osteons in the cortex and on the proportion
of cortical to cancellous bone. Turnover, or
remodelling, usually occurs at a rather higher rate in
cancellous bone than in cortical bone, and thus more
calcium ions are available for chelation with TC.
The duration of binding of TC in bone has
been shown by Frost (1961) to be for at least 9 years
and the drug can be detected with ease in bone sections
by the characteristic fluorescence when exposed to
ultraviolet light. These properties can be utilized
to study skeletal metabolism, particularly as there is
preferential incorporation into new bone deposits.
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It appears from the work of Harris, Jackson
fib Jowsey (1962), comparing microradiography, Ca^
autoradiography and fluorescent microscopy after TC,
that all actively growing surfaces are internely
labelled by TC. There are, however, other low-
intensity sites of incorporation of TC, namely diffuse
distribution, "edge sclerosis" (a thin rim of increased
mineral density lining the inner- edge of some non-
growing osteons, trabeculae and Volkmann*s canals), and
finally surrounding many lacunae. A point which must
be stressed is that actively growing bone shows a higher
concentration of the fluorophore and is therefore
distinguishable from the low-intensity sites detailed
above. However new bone formation is often so foGal
that interpretation of metabolic activity based on
observations of a limited sample is hazardous.
Nevertheless, as Frost et al. (1960a) have shown, TC
is most valuable as a safe, convenient and important
tool in the study of bone formation in vivo. As TC
appears to be fixed in bone, giving staining of
Haversian canals, osteocyte lacunae in Haversian systems
and calcified cartilage whilst they are actively
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mineralising, retrospective studies for many years
after TC administration may be performed.
Bat ho logics 1 States of Bone
A• Teratogenic and Bone Growth Effects
TC has been shown by Bevelander and his
co-workers (1960ab) to cause skeletal mal-development
when given to the larval sand dollar and to the chick
embryo. This work was extended by Urist& Ibsen (1963)
who found that saturation of the rapidly growing skeleton
of a chick with GTC caused the development of rachitic
deformities and interference with calcification.
Tubaro (1964) continued this work on chick embryos and
found that D10TC produced many more foetal abnormalities
than did TC or CTC, a feature which he related to its
greater stability.
In humans, apart from a warning of the
theoretical danger with one case report from Carter &
Wilson (1962) in relation to foetal danger, no further
cases appear to have been reported. Nevertheless the
premature infant was shown by Cohlan et a 1. (1963) to
have a temporary 40% depression of normal skeletal
growth if given TC, and in the rat a 28% depression of
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foetal growth could be caused by transplacental
passage of the drug, so there is good reason for
caution in the prescribing of this drug in pregnant
women or infants.
B. Pyogenic Qsteemyelitis.
This disease even in this day of effective
antibiotics still poses a therapeutic problem. Prost
et al. (1960b) point out, using TC as a marker in
their experiments, that bone is highly impermeable
when dead even though those channels containing a patent
blood supply in life showed surface staining whilst TC
was being administered. If small portions of dead bone
are present slow diffusion of antibiotic to the bacteria
in the many spaces of bone might be effective in
sterilising the bone, provided the drug be given for
long periods of time. However, large pieces of dead
bone will never be permeated and thus the disease runs
a relapsing course from a bacterial reservoir of the
dead bone of very high diffusion impedence.
The antibacterial activity of TC after its
deposition in bone has been studied by Anderson et al.
(1959) using rabbits' bone; the animals having been
prepared previously with TC. Ihose animals which
had received parenteral TC within 96 hours of sacrifice
showed an antibacterial activity against test organisms,
but if more than 96 hours had elapsed there was no
inhibition of organisms even though the bone showed
fluorescence. The explanation may be either that of
slow diffusion of the drug in bone or the formation of a
firm inactivating bond to bone at about 96 hours in the
process of raineroligation. In contrast Boyko (1959)
reports the retention of antibacterial activity by bone
fluorophore for up to 5 weeks in mice and 2% months in
rabbits (the limits of his observations) after
administration of TC. Plaza-Roca (1959) suggests that
possibly liberation of active antibiotic might occur
during resorption of bone, such as bore grafts if
obtained from the iliac crest, the last region in man
to ossify completely.
C. Fractures
Malek S-. Eolc (I960) studied the penetration of
CTC into animal tissues affected by different pathological
processes. In fractures intensive absorption by the
entire bone from .joint to joint was shown by highly
intense fluorescence, while the two broken ends and
adjacent area of the fracture did not fluoresce. The
fractured bone seemed to absorb the antibiotic to the
detriment of other bones. In later stages of healing,
fluroescence moved increasingly into the area of the
callus. Experimental fractures have been studied by
Urist & Ibsen (1965) who found that during the first
week of healing the bone formed in the callus was
highly reactive, binding OTC in high concentratiohs
with progressive reduction thereafter,
D. Osteoporosis
The phenomenon of TC fluorescence has been
used to study this condition (Urist et al. 1962b) but
results are difficult to interpret because fluorescence
can be seen only in that of the skeleton which is
exchangeable, labile or reactive, whereas the 99%
remaining is not labelled. Patients with osteoporosis
may have high or normal accretion rates, or even, in
severe senile osteoporosis the accretion rate may be
low (Urist & McLean, 1963),
E. Arthritis.
Studies have been made on arthritic femoral
heads by various workers including Milch (1965) with
the observation that shortly after an injection of TC
these femoral heads do not exhibit fluorescence as
would be expected if the blood supply were intact.
This failure of blood supply was found in 811 forms of
hip arthritis, including rheumatoid and post-traumatic
forms, but whether this is a primary or secondary
phenomenon is uncertain.
F. Paget's Disease of Bone
McLeay et al. (I960) end Urist & Ibsen (1965)
have noted vivid TC fluorescence in the calcified mosaic
of Paget'8 Disease with the suggestion of high calcium
turnover in the affected sites.
The Nature of the Fluorophore in Bone
Titus (1958) investigated the fluoro¬
phore found in bone in TC-treated rabbits. By similar
methods to those given on tumour fluorophore (see
earlier) they demonstrated that the fluorescent material
in bones after TC was most likely to be the unaltered
TC as it was possible to obtain the absorption spectrum
of TC from bone-fluorophore solution. Paper chromato-
graphy and the use of strong acids supported this
conclusion as with tumours. They found that the
fluorescent material could be removed by
ethylenediaminetetra-acetic acid (EDTA) at pH 7.3
from the fluorescent bone and since this compound is
known to chelate metallic cations, it was suggested
that such metallic cations were involved in the binding
of TC to the bone structure. This suggested that TC
is either primarily bound to the inorganic structure
of bone or is bound to the organic matrix through
metallic cations. This was felt to be consistent with
previous observations by Regna et al. (1951) that these
drugs form chelate compounds with metallic cations,
such as calcium, at physiological pH.
Finerman & Milch (1963) reported additional
in vitro evidence for the binding of TC to calcium.
Using ground fat-free, cortical animal bone powder
treated with buffered TC solution, they were able with
a spectrophotometer to calculate the percentage TC
absorbed. Significant binding occurred to the fat-
free bone powder. No binding was observed however with
bone salt which had been pretreated with EDTA and which
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contained no detectable calcium. Ethylenediamine (ED)
was used to treat the bone powder to remove the organic
phase and this preparation avidly bound TC to the same
extent as did a preparation of calcium phosphate, but
to a greater extent than calcium carbonate. It
therefore appeared that ED treatment, by removing the
organic phase, appeared to remove either a diffusion
barrier or an otherwise hindering bond between crystal
and matrix phases. An apparently greater total calcium
crystal surface, approximating to that of inorganic
calcium phosphate, was thus made available to the TC.
Conversely, treatment with EBTA in effect removed the
crystal phase so that no TC binding occurred. These
workers therefore concluded that persistence of TC in
biological tissues is probably directly related to the
calcium content of that tissue. They felt that it seemed
reasonable to conclude that TC probably reacted primarily
with calcium ions in hydroxyapetite-seeded nucleation
sites on collagen fibrils. This would certainly explain
the localisation and persistence of TC in vivo in newly
proliferated bone and in certain areas of calcified
cartilage as described by Milch et al. (195e» 1961).
Deleu & Bohr (1964),having shown a diffuse
uptake of TC by bone grafts, investigated further this
phenomenon in bone devitalised by freezing, boiling,
storing in alcohol or by simply keeping it as fresh
bone. For 24 hours the bone was soaked in a solution
of TC in citrated plasma and then washed for 48 hours.
They found that mineralized dead bone took up TC on
every surface. As in living bone there was a greater
uptake in the growing part, in the zone of demarcation,
within the osteoid seam. In non-growing surfaces,
like osteons which show edge-sclerosis or in resorption
cavities, there was limited uptake. Besides this
surface incorporation, there was also a diffuse uptake
which was more prominent in cancellous than in cortical
bone. Thus the uptake of TC is not impendent on the
activity of living bone cells or on the physical
properties of the intercellular components, which are
greatly modified by boiling or alcohol. The binding
cannot be directly related to calcium uptake because
there were no free calcium ions in the citrated plasma.
Additional support for calcium being an
important factor in the binding of the TC group of drugs
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in biological material was offered by Ibsen & Urist
(1962) in detailed studies of reactions of OTC and
varying levels of calcium at physiological ranges of
pH, ionic strength and drug concentration by spectro-
photometric methods. This revealed a stepwise
addition of metal to OTC. When 1:1 or higher calcium
to OTC complexes are formed it seems unlikely that all
of the co-ordinating positions of calcium are satisfied.
This apatite-surface calcium could react with OTC and
permit accumulation of this fluorophore in bone.
Possibly spacial configuration of apatite-surface
calcium allows two or more calcium atoms to bind
simultaneously one molecule of TC, enhancing the force
of attraction.
In an accompanying article Urist et al. (1962a),
using biological effects of altered concentrations of
free ionised calcium and OTC on isolated frog's heart,
were able to obtain remarkable agreement with the concept
of a 1:1 complex of metal to OTC found by spectrophoto¬
metry. They point out that the usual human dosage of
this drug ( 1 gm. per day) produces a serum
concentration of approximately 1.0 ^ig. per ml., of
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which 75% is protein-bound and only 25% free in solution
to form complexes with metal ions. Under these
conditions calcium and OTC formed complexes chiefly in
the 1:1 ratio, but in bone matrix where calcium ion
concentration may be higher, the proportions might
increase to 2tl or even 3s1. Because of the high
concentration of calcium ions, in relation to other
polyvalent ions in blood, the Mass Law would operate in
favour of calcium complex formation and this effect would
be localised and enhanced in calcifying tissues.
These authors point out that although the
inorganic calcium phase of the binding In bone is
emphasised, it is also possible that TO forms complexes
with an organic constituent during synthesis of
calcifiable new matrix. Non-calcifying tissues such
as tumours, healing wounds, sclera, tendons, scales,
hair and feathers fluoresce, particularly after prolonged
administration of TC and this could be construed as
evidence that the fluorophore in bone is bound to
polysaccharide (Plaza-Roca, 1959)» polypeptide (Loo et ai.
195?)* or collagen (Milch et a 1., 1961).
It is suggested by Urist & McLean (1963) that
the three possible sites of binding of the fluorophore
in bone are on the crystal surfaces as complexes with
calcium, as complexes with collagen or in complexes
that share calcium ions with polysaccharide in newly
mineralized tissues (Fig. 3«).


















Site A (Pig. 3.) is well supported by the
previously quoted evidence of binding of OTC by apatite
crystals in aqueous solutions and by anorganic bone.
Site B is difficult to prove since collagen binds only
relatively small quantities in vitro and it cannot be
divested of all mucopolysaccharide and metal ions that
form complexes with TC. Site C is considered a
possibility but direct chemical evidence is lacking.
Although the walls of gastric ulcers have a
tendency to bind TG in much smaller quantities and for
shorter periods than tumours (Hakkinen & Hartiala, 1959)
and contain much larger concentrations of sulphate than
does gastric mucosa (Hakkinen, 1959)« this does not prove
that I'C binding in bone or elsewhere depends on sulphated
mucopolysaccharides, as has been suggested by the above
authors•
Whereas collagen binds TC in vitro in small
amounts, the complex does not fluoresce and probably
does not exist in bone matrix. Osteoid is non-
fluorescent in rachitic rats treated with TO.
It therefore seems likely in bone that the
large TC molecule is bound to the bone mineral
Biicroerystallites in the crystal surfaces during
deposition (Urist & Ibsen, 1963)*
Thus the relatively large amount of TC bound
in newly deposited mineral can be explained by smaller
crystallites, with a. relatively large surface area
suspended in tissue with maximum content of water,
and higher chemical reactivity of hydrogen-bonded,
calcium-deficient apatite. The high reactivity of
the bone mineral with TC declines in less than 24
hours after deposition possibly in part from trans¬
formation of calcium-deficient apatite to hydroxy-
apatite. In addition the crystals grow larger,
thereby decreasing the surface area, while the matrix
becomes denser, thus enclosing the inorganic phase
in organic matrix that is relatively impermeable to
large molecules such as TC.
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PART 4
FLUORESCENCE IN OTHER TISSUES
Calcified Tissues
A. Teeth, There is a voluminous dental literature
on the staining of teeth with the TC group of
drugs. The brown pigmentation seen in childrens'
teeth, particularly after prolonged treatment
with TC was described by Shwachman et al. (1958).
The teeth are fluorescent under ultraviolet light
but the disfiguring brown pigment is a degradation
product of TC. Wallman & Hilton (1962) proved
the presence of TC in such teeth by ultraviolet
spectroscopy, but of much greater import would
seem to be the enamel hypoplasia which may be
associated, especially in neonatal patients.
Indeed transplacental passage has resulted in
stained teeth in the foetus when the drug was
administered to the mother (Kutscher et al., 1963).
B. Calcareous Tendinitis deposits removed after
exhibition of OTC by Urist & Ibsen (1963) gave
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strong homogeneous fluorescence with the
suggestion that the looser packing of the apatite
crystals favours the binding of the drug#
C. Metastatic Calcification. Using dihydrotachysterol
(A.1.10), Hakkinen (1958) induced metastatic
calcification in rats particularly on the surface
of the kidneys, but also in the stomach, lungs and
heart, which was readily demonstrable as Intense
fluorescence as the animals had received TC as
well.
D. Calculi. The property of fluorescent marking of
calcified calculi both renal (Mulvaney et al».
1964) and biliary (Aekerman & McFee, 1963) may
perhaps be of use in the future in studies on the
life history of calculi. It may be mentioned that
no demonstrable inhibition of bacterial growth
occurred from particles of fluorescent urinary
calculi.
Mon-Calcified Tissues
A. Gastric Ulcere. Hakkinen (1959) studied TC
fluorescence In experimental gastric ulcers in
animals and noted persistence of fluorescence for
a few days, but from my own and other authors*
observations it would seem that in benign gastric
ulcer in man any fluorescence is minimal and
short-lived and not to be confused with the
gross persistent fluorescence seen in malignant
tissue.
Tissue In,iur.y Again Hakkinen (1959) reports
fluorescence persistent for 5 days in areas of
tissue injury as does Mustakallio (1962) in
relation to traumatic injuries, but it seems
likely that in these situations one is simply
seeing the results of absent blood supply in
sloughs and necrotic tissue from whence TC once
deposited cannot be cleared.
Ischaemic Tissues Malek et a 1., (1965a) have
studied the distribution and temporary retention
of TG drugs in experiipental animal kidneys and
have shown far less localisation in experimental
pyionephritis than in renal ischaerala, where
calcification is more prominent. These findings
are in accord with the TC fluorescence persistent
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in areas of heart muscle which have been the
site of myoc rdial infarction (Malek, 1963b).
D. hicro-organisms and, parasites. In studies of
protozoal and bacterial phagocytosis it was
found by Du Buy et al. (1964) that TC was taken
up, as shown by fluorescent microscopy, by
extracellular organisms, but that until the
hoot cell died the intracellular parasites were
not visible.
Sexen & Vainio (1964) found that the
fluorescence of fC, which was incorporated into
degenerating cells, proved to be a sensitive
marker of early viral eytopatkic effects.
At the other end of the scale of micro¬
organisms, it h&e been mentioned by Tobie & Beye
(I960) that loa-loa, the eye-worm, fluoresces
through the skin after the sufferer has been
given TC, and that this may be of value in
diagnosis.
E. Pancreatitis. The affinity for calcium of the
diseased tissue of acute pancreatitis is
presumably the explanation of TC-induead
fluorescence In this condition as reported by
Aeteernan % WcFee (1965) and in experimental scute
ps sorest ic necrosis (Malek & Kolc, I960).
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SECTION IV
DIAGNOSTIC APPLICATIONS OF TETRACYCLINE
FLUORESCENCE IN TUMOURS
Introduction
The property of TC fluorescence of malignant
tumours may be utilised as a diagnostic aid. This is
not to say that the role of radiology, endoscopy and
the usual methods of exfoliative cytology have been
superceded, but rather to assess the value of TC
fluorescence as an additional method. At present the
only endoscope capable of transmitting ultraviolet
light has been developed by Whitmore (1964, 1965) when
he used a special quartz fibre-optic cystoscope in
the early diagnosis of bladder tumours. The two
problems in the design of such an instrument are the
heat produced by the ultraviolet light source and the
transmission of the ultraviolet light, which is
absorbed by glass so that quartz transmission of the
rays has to be used. So far an appropriate gastroscope
has not been developed. Apart from direct examination
of malignant lesions of skin, the oropharynx and
operative specimens, the main field of interest has
"been in exfoliation of TO fluorescent material from
malignant tumours# The major part of the work on
exfoliated material both by myself and, since embarking
on this project, by a large number of other authors,
has been on gastric lavage material. Other exfoliative
sites have included the bronchus, ascitic and pleural
fluids and, in a few instances colonic and duodenal
lavage specimens.
The advantage of TC fluorescence is that it
does not require a highly trained cytologist for its
recognition, a point of some importance in places
without the services of such a specialist. These is
an increasing shortage of trained cytologists and
technicians because of the expanding programme of
routine cytological surveys, particularly in relation
to cancer of the cervix uteri.
It seems important to assess the reliability
of the TC fluorescent test in exfoliated tumour
material, as compared with routine cytology, for the
former method is so much quicker and easier than the
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complex staining and scrutiny of standard eytological
slides. In addition it may be that the naked-eye gross
assessment of TC fluorescence, whilst crude, neverthe¬
less is assessing degenerate tumour material which the
exfoliative cytologist would be unable to identify.
PART 1
PERSONAL SERIES OP GASTRIC LAVAGE STUDIES
Studies of patients with both benign and
malignant gastric lesions have been performed personally
since 1962 at the following hospitals:- Royal Sussex
County Hospital, Brighton, Brighton General Hospital,
King's College Hospital, Dulwich Hospital, Brook
Hospital and Yfoolwich Memorial Hospital. All aspects
of the procedures have been performed by myself alone
and, so as to attain uniformity of technique, in no
instance was the gastric lavage delegated to anyone
else. The examination of lavage material has also been
performed by myself, although in addition e second
medical observer was asked to make an independent
assessment of fluorescence compared with a dried smear
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of known TC on filter paper. These independent
observers' assessments of fluorescence in every case
agreed with my own. At times it was obviously
Impossible for me to be completely unbiased in asses¬
sing fluorescence where the patient was in my clinical
care, but in those cases examined from other units,
care was taken not to make a clinical diagnostic
assessment before examining for fluorescence.
METHODS
The details of TC dosage are given later,
together with the intervals from treatment to lavage,
when reporting the results of the lavages of the various
groups of patients.
If aluminium hydroxide gel, v/hich has been
shown to reduce absorption of TC (Waisbren & Hueckel,
1950), was being given it was stopped and an alternative
antacid used. Ho alteration was made to the diet,
although theoretically milk products should have been
avoided to improve absorption of TC (Scheiner A Altemeir,
1962).
The main principles of the lavage technique
are those of Raskin et si. (1958), although with some
modifications detailed below. At first the overnight
residue, preliminary wash with normal saline, and
buffer lavage specimens were scrutinised separately.
However, it was felt that this imposed too greet a
number of slide examinations for the cytologist and
that if the first two specimens were not included
desquamated material might be lost. After the first
6 cases a pooled specimen of overnight residue and
normal saline lavage was examined, care being taken to
neutralise the lavage fluid immediately the tube was
withdrawn.
The patient was fasted overnight for 12 hours
and the lavage performed between 8 and 10 a.m. Sips
of water were allowed to aid the swallowing of the
stomach tube. A plastic Ho. 18 levin stomach tube
was passed either by the nursing staff or myself,
preferably pernasally, but occasionally the tube had
to be passed by mouth if there was nasal obstruction.
Confirmation of its position was obtained by aspirating
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residual gastric juice, at first this was kept separate
from the gastric washings but later it was pooled as
frequently it was of small volume. The solutions used
for gastric lavage were at first buffered isotonic
acetate solution to a pH of 5»5» but usually sterile
normal saline was used as being more readily available.
The acetate buffer was prepared as follows:- 1.3 parts
solution A (0.2KAcetic Acid, 11.6 ml. to 1 litre)
with 8.7 parts solution B (0.2MSodium Acetate Tri-
hydrate 27 gm. to 1 litre). The amount of solution
used varied. If the resting juice obtained was clear
1 pint (540 ml.) was used for lavage. If however the
gastric juice contained any food residue, a cleansing
lavage was first performed with as much saline as was
necessary to obtain a clear return. The diagnostic
lavage was then completed in the following way,
A vigorous lavage was always performed using
either a 50 or 100 ml. glass syringe or using a 200 ml.
metal, or metal and glass, le Riche bladder syringe.
A more powerful jet of fluid can be delivered by the
larger syringes and it is thought that this is
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important in obtaining exfoliation.
Half of the total amount of solution was
forcibly injected down the tube with the patient
lying supine, the head being supported by two pillows.
For 5-10 minutes repeated withdrawal and reinjaction
of fluid was performed. The patient then turned to
lie on his right side and part of the remaining fluid
was injected, withdraws! and reinjected. This procedure
was repeated with the patient prone and then lying on
his left side. In each of these four positions the
epigastrium was vigorously massaged unless there was
too much tenderness, and the position of the tube was
frequently raised or lowered.
Finally with the patient lying supine again
the stomach was emptied and the tube removed. The
whole procedure usually took about 30 minutes.
Preparation of the Smears
i i ii I ii ■ — - — .
Immediately gastric lavage was completed the
contents were brought to neutrality, if necessary, by
the addition of sodium bocarbonate solution, using
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litmua paper as indicator.
As soon as practicable, and always within 45
minutes, part of the lavage fluid was put into four
universal containers and centrifuged at 3000 r.p.m.
for 15 minutes. The remainder of the fluid was sent to
the laboratory for routine exfoliative cytology after
staining either with Papanicolaou stains or haema-
toxyliri and eosin.
The supernatant fluid was decanted from the
universal containers and the sediment smeared on to
Whatman No. 3 filter paper and in some instances on to
glass microscopic slides. The smears were allowed to
dry in a warm room, not exposed to daylight which
enhances the gradual decay of the fluorescent property
of TC.
Examination of the Smears
As soon as practicable, but never more than
6 hours later, the smears were examined in a darkened
room with a portable ultraviolet lamp described earlier.
The smears were viewed by holding the filter paper (or
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slide) over the top of the box containing the lamp so
that the beam of ultraviolet light was directed away
from the operator to prevent direct ultraviolet light
entering the eyes. The smears were held within a few
inches of the light and compared with a standard
obtained by allowing TC solution to dry on a filter
paper. This comparison with known TC fluorescence
was of importance in differentiating the golden-yellow
fluorescence of TC from other fluorescence, particularly
white fluorescence or dull yellow colour which may be
seen in normal gastric juice. Photographs are shown
on page 226, but do not accurately reproduce the true
fluorescent colours.
RESULTS OP GASTRIC FLUORESCENT TEST
Pour groups of patients have had their gastric
contents examined for fluorescences-
1. Juice from patients with
Peptic Ulcers - NOT prepared with TC
2. Lavage from patients without
Gastric Carcinomas - prepared with TC
3. Lavage from patients with
Gastric Carcinomas - NOT prepared with TC
4. Lavage from patients with
Gastric Carcinomas - prepared with TC.
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The ease material and results of these groups are
described separately.
1, Juice from Patients with Peptic Ulcers - HOT
'
Prepared with Tetracycline
The juice was a portion of the resting juice
obtained from 12 gastric ulcer and 12 duodenal ulcer
patients, who had not received TO, in the course of a
routine assessment of gastric secretory function.
10 FLUORESCENCE of the characteristic golden-
yellow was seen on exposing the neutralised dried
smears to ultraviolet light. In many instances although
there were no traces of typical yellow fluorescence,
there was to be seen either e white fluorescence,
particularly on the filter-paper smears, or a dull
yellow staining (not fluorescence) of bile. No
difficulty was encountered in differentiating this
from the time TC fluorescence as shown by a dried
smear of TC solution on filter paper#
2, Lavage from Patients without gastric Carcinomas -
Prepared with tetracycline
Case Material
These 45 patients comprised*-
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19 patients with Benign Gastric Ulcers
3 patients with Duodenal Ulcers
13 petients with dyspepsia in whom no definite
evidence of ulcer could be found, although
sometimes Ba meal and Gastroscopy were
suspicious
3 patients with Pernicious Anaemia
1 patient with nutritional iron deficiency
anaemia
1 patient with hypertrophic gastritis
2 patients with carcinoma pancreas
1 patient with carcinoma gall bladder
1 patient with previous gastrectomy
1 patient with previous gastro-enterostomy
All these patients had at least one barium
meal examination, and certainly all the patients with
a gastric ulcer haa at least two such radiological
examinations. Gastroscopy was performed in 16 patients.
Abdominal operation was performed on 15 petients. In
those seven who had a partial gastrectomy for gastric




ulceration with no suspicion of malignancy. In the
two patients with carcinoma of pancreas and the one
with carcinoma of the gall-bladder, provided histo¬
logically either at laparotomy or autopsy, there was
no Invasion of the stomach.
It is thought that in all cases, the
possibility of gastric carcinoma has been virtually
excluded by laparotomy, autopsy, repeated barium meal
examinations, gastroscopy or clinical follow-up over
a period of at least 6 months. The possibility that
one of these patients will develop an overt carcinoma
of the stomach in the future cannot be denied, but
seems unlikely. Those patients with gastric ulcer who
have not had gastrectomy all showed radiological or
gastroseopic evidence of complete healing#
Tetracycline Preparation
In 24 of the 45 patients, TC preparation was
with 5 gm, TC orally in divided doses over 5 days, and
in a further 6 patients with the same amount over 2-§
days. In the remainder given oral TC the total dosage
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ranged from 6 to 8 gm. over a period of 3 to 10 days.
The intravenous route of administration was chosen for
3 patients because of vomiting and a single intravenous
dose of 1.0 gm. given over one or two hours.
Interval
The interval between completing administration
of TC and gastric lavage, was from 30 to 48 hours. The
interval was 36 hours in 26 patients, 30 hours in 14
patients, and 48 hours in 5 patients.
Results
In 43 of the 45 patients, no characteristic
golden-yellow fluorescence could be seen, although
frequently there were white fluorescent particles in
the smears. On two examinations a dull yellow bile
staining was associated with the white fluorescence
but the colour was not at all lihe that of TC.
In 2 patients' smears there was a trace of
golden-yellow fluorescence indistinguishable from
that of TC. Each of these pctients had had a standard
5-day course of 5 gm. of TC end an interval of 36 to 48
hours respectively.
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The first of these felse-positive results was
from e nan of 60 years who suffers from systemic lupus
erythematosus taking prednisone, whose blood urea wee
normal. He had dyspepsia for 6 months, and barium
meal showed a lesser curve gastric ulcer, as did
g&stroscopy, although there was no suspicion of
malignancy on these examinations. A few weeks later
laparotomy was performed with a view to gastrectomy,
but on opening the stomach the ulcer was seen to be
soundly hei&led, so excision wee not performed. Two
years later he is well with no abdominal complaints
whatsoever.
The second of these apparently fallacious
results was in a lady of 57 years with & history of
one year typical ulcer dyspepsia and occasional
vomiting# On two barium meals there was a persistent
smell lesser curve ulcer crater which had dleappe- red
on later barium meal and no abnormality could be seen
on gestroccopy, Six months later she was symptom-free
and gaining weight.
It is possible that in the future these two
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p etients may develop a gastric carcinoma and they are
being followed carefully at clinic with this in mind.
Emphasis is laid on the fact that in both these
patients the yellow fluorescent result was extremely
weak and in each was present in only one of the 4
smears.
Gastric cytology was performed by the
pathologists of the hospitals concerned on part of
the gastric lavage in all but two of the patients, and
in none were malignant cells seen.
3. Lavage from Patients with Gastric Carcinomas - ROT
Prepared with Tetracycline
Only 5 of these patients have had a gastric
lavage performed before the exhibition of TC and in
none of these has there been any trace of golden-yellow
fluorescence. It would probably have been wise to have
performed such a pre-TC test on all patients but this
has been undesirable in the ill patients, and often
difficult to arrange where surgical intervention wee
pressing.
107
4. Lavage from Patients with Gastric Carcinomas -
Prepared with Tetracycline "
C&se Material
There were 30 patients with malignancy studied
by gastric lavage after TC preparation. Of these, 15
had gastrectomy or biopsy proof of gastric carcinoma,
a further 8 patients had laparotomy proof of gastric
malignancy although no biopsy was taken, and in the
remaining 7 patients the clinical course and radiological
appearances virtually proved the diagnosis of gastric
malignancy.
Of the 15 histological specimens examined 4
were well-differentiated, 6 were poorly differentiated
(3 of the mucous-secreting or "signet-ring" type), 1
very poorly differentiated and 1 anaplastic type of
adenocarcinoma of the stomach. There were 2 cases with
linitis plastica without microscopic invasion of the
mucosa (see Appendix 3).
Tetracycline Dosage
Varying methods of preparation of the
patients with TC were employed, partly to suit the
convenience of the surgeon, and partly to assess the
various possible dosage regimes in relation to lavage
fluorescence. In those patients who were vomiting*
the intravenous route was employed to ensure no
confusion of results due to impaired gastric emptying
and absorption of the drug.
The numbers of patients receiving the various
dosage regimes are as follows
500 mg. qds for 2-g days - 5000 mg. - 11 patients
250 mg. qds for 5 days - 5000 rag. - 11 patients
500 mg. qds for 4 days - 8000 mg. - 2 patients
1000 mg. intravenous over
-§• - 4 hours - 1000 mg. - 6 patients
Intervals from Tetracycline to Lavage
The intervals from stopping the TC to the time
of lavage varied from 30 to 48 hours, with the most
usual interval being about 36 hours. It was thought
that any shorter interval might produce false-positive
results through failure of TC clearance from normal
body fluids.
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Routine Exfoliative Cytology was performed "by the
Pathology Departments of the various hospitals.
Regrettably cytology was only performed in 18 instances
of the 30 specimens of lavage material. The shortage
of trained staff in some of the hospitals and the need
on occasion to perform the lavage at weekends rendered
it impossible to obtain cytological examination of the
lavage material in 12 cases.
Results of Fluorescent Test in Gastric Malignancy
The individual details of the various cases
are given in Appendix 3% and in Table 4. Of the 30
patients with gastric malignancy pretrested with TC,
23 (77$) showed a positive gastric fluorescent test,
Eight patients showed brilliant fluorescence, 10
patients showed moderate fluorescence and 5 weak, but
definite, fluorescence. There was great variation
between the amount and intensity of the TC fluorescence
on the smears. In some the whole of the dried smear
showed small flecks and large spots of golden-yellow
fluorescence whereas in others the positive result
could consist of a few minute flecks of characteristic









































































5 5 days 0 36
5 2I days 0 36 +♦
5 2J days 0 30 0
5 ?.% days 0 36 ♦+
5 2\ days 0 36 ♦
5 5 days 0 36 +
5 2 2 days 0 32 +
1 U hrs. IV 1*8 +++
1 i hr. IV UO
8 U days 0 36 ++
5 5 days 0 36 0
5 2\ days 0 36 0
1 U hrs. IV 36 ++
5 5 days 0 36 0
0 U days 0 36 ++
5 5 days 0 36 +++
5 5 days 0 30 0
5 22 days 0 30
5 days 0 30 ++
5 5 days 0 32 +++
5 5 days 0 30 0
5 2j days 0 30 ♦♦
1 1 hr. IV 30 ♦
5 5 days 0 30 ++
1 1 hr. IV 32 +♦+
1 1 hr. IV 30
5 5 days 0 30
5 5 days 0 32 +++
5 2J days 0 30 ++♦
5 5 days 0 30 0
Individual case details in Appendix 3.










+ Malignant cells seen
?+ Suspicious of malignant
0 Mo malignant cells seen
N.D. Cytological examination
ease of detection was the guide to the assessments of
"brilliant", "moderate", and "weak" which were dependent
on the amount of fluorescence on the overall appearance
of the smears, rather than the actual intensity of any
particular fleck or spot of fluorescence.
In 7 cases (23$) of gastric malignancy, there
was no characteristic golden-yellow fluorescence visible
on the dried smears. None were classified as dubious
or equivocal as it was felt that such results are not
of value to the clinician, and a definite statement
as to the presence or absence of fluorescence was
essential. The spreading of half the smears on filter
paper and half on glass slides was found to be of value
in assessment of the results, particularly when the
wet smear on the filter paper on drying produced a
white ring of fluorescence around the deposit.
Especially in these instances, the examination of smears
on the slides when reviewed obliquely under the ultra¬
violet lamp was helpful in deciding on the question
of true TC fluorescence.
It was with increasing facility that the
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scrutiny of the smears could he assessed and,
particularly in the early cases, it was found in¬
valuable to compare the smears with a known TC smear.
The presence of white fluorescence, presumably from
traces of food debris, and of yellow non-fluorescent
bile staining could be a source of confusion unless
reference was made to the standard TC smerr, where the
true distinctive golden-yellow fluorescence of TC
could be seen under the ultraviolet lamp.
In a few instances dried smears on glass
slides were examined under an ultraviolet microscope,
but the intensity of fluorescence of a non-specific
type so confused the appearance of the smears that it
was felt that no more useful information could be
gained from this technique than from the naked-eye
scrutiny of the smears under an ultraviolet lamp.
Relationship of TC Fluorescence to Tumour Types
An attempt has been made to correlate the
positive results obtained with the histological types
of the tumours. The 15 gastric carcinomas examined
histologically as to tumour differentiation in
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relation to the results of the fluorescent test are
given in Table 5»
Fluorescent Test





Table 5* Relation of Fluorescent Test Results to
Tumour Differentiation
It can be seen that from the small number of
caseB available no p rticular pattern of histological
differentiation and fluorescent result can be demonstrated.
The gross appearance of the tumour was
classified from an assessment of the pathological
appearances of the stomach, the operative findings if
gastrectomy was not performed, or the radiological or
gastroscopic appearances. It is realised that this is
a crude assessment for what may be, for example, a
plaque of cancer at one time may through necrosis
appear like a malignant ulcer later. Similarly on
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radiology, a filling defect may be thought to be of a
"cauliflower" tumour whereas more accurately it should
be regarded as a large plaque. Nevertheless, the
assessment into broad macroscopic types is given below
with the results of the fluorescent test in Table 6.
Fluorescent Test
Type of Tumour Brilliant Moderate' Weak Nil
"Cauliflower" 5 6 2 2
"Plaque" 3 2 13
Ulcer - 1 12
Linitis Plasties - - - 2
Table 6. Relation of Fluorescent Test to Macroscopic
Tumour Type
In the 7 cases (23^) where a negative fluor¬
escent result was obtained, there seems to be a ready
explanation in two instances (cases 3 and 17, Appendix
3, Table 4), where at operation was found linitis
plastics without apparent histological invasion of the
mucosa, so that malignant tissue would not be available
for exfoliation. In case 17 (Appendix 3) the gastrectomy
specimen was examined with the ultraviolet lamp shortly
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after the lavage. Although there was vivid fluorescence
of the cut edge of the stomach, no appreciable
fluorescence could be seen on the mucosal surface and
it is not surprising that in the lavage material no
exfoliated fluorescence could be seen. (In one of the
other negative fluorescent results (case 12, Appendix
3.) vigorous lavage was not performed because of the
presence of much blood, which may explain the failure
of the test in this case. In the remaining 4 negative
results, there is no ready explanation for the failure
of fluorescence. It may be that lavage was not
sufficiently vigorous to cause shedding of tumour
material into the stomach, or it may be that one is
encountering the individual variation of tumours in
their TC uptake, as suggested by Case 11, where exam¬
ination of the excised tumour revealed only very weak
fluorescence.
Prom these results it would appear that the
tumours presenting as cauliflower-like filling defects
or plaques of malignant tissue with rigidity and
irregularity of the stomach on barium meal are the
most likely to "be diagnosed by the TC fluorescent test.
It would seem likely that these two gross types of
tumour have greater exfoliation of tumour cells, by
virtue of their greater surface aiea, or perhaps the
weakness of their stroma, than does the malignant ulcer.
There are however too few malignant ulcers in the series
for this point to be definitive.
The fact that most of the carcinomas were
advanced cases was unavoidable in view of the unselected
nature of this series. It is most regrettable that by
the time the majority of patients with gastric carcinoma
present at hospital their disease is so widespread as
not to be curable by surgical intervention.
Relation of TC Fluorescent Results to TC Dosage Regimes
As previously detailed, there were 4
different regimes of TC administration and it is
important to analyse the fluorescent results in
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1000 mg. intravenous 2 3 1-
Table 7. Relation of Fluorescent Test to TC Regime
From Table 7. it will be seen that each of
the 4 regimes of preparing the patient for the test with
TC was capable of inducing typical fluorescence in the
gastric lavage material.
Even though the intravenous method utilises a
much smaller total dose it would appear that the high
blood levels achieved compensate for the much smaller
amount of TC. In any case parenteral administration of
TC is essential for some cases where gastric stasis may
lead to fluorescent particles from the tablets remaining
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in the stomach for more than the minimum 30-hour
interval from stopping the drug to performing the test.
Gastric stasis or vomiting may also lead to impaired
absorption and the possibility of a "false-negative"
result. The minimum intravenous dose has not been
ascertained but no difficulties were encountered with
1000 mg. TC being given over a period of more than
hour, although if given more quickly unpleasant
flushing may trouble the patient.
The large total oral dose of 8000 mg. was
effective but, as it was tried in only 2 patients,
evidence is insufficient to say whether increasing the
TC load achieved more fluorescence in the tumour and in
the resultant lavage material.
A total oral dose of 5000 mg. was given to 2
groups of 11 patients, the first receiving 500 mg.
q.d.s. for 5 days. No unpleasant side effects were
encountered with the more concenorated regime. The
numbers do not permit any deduction as to which regime
is the more efficient in preparing the patient. There
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were 5 negative tests with the 5-day regime as compared
with 2 negative tests with the 2-§- day regime, but on
the other hand there were more brilliant fluorescence
results with the longer course.
A dosage of 250 mg. q.d.s. takes 5 days to
achieve a blood TC level of 3 tc 4 ug./ml. whereas
the 500 mg, q.d.s. achieves 4 ug./ml. "within 3 or 4
days" (howling, 1955). If indeed the blood level
rather than the duration of exposure of the carcinoma
to TC is the important factor in determining the
intensity of fluorescence, it would seem logical to
use the higher dosage of 500 mg. q.a.s, In addition
the delay of a week in being able to report the
fluorescent results is often undesirable, so the
compressed regime of 2-| days TC administration would
appear to be perfectly adequate for routine use.
Relation of TC Fluorescent Results to the Interval
from TC to Lavage ~~~~
The interval from discontinuing TC to time
of lavage varied from 30 to 48 hours. In 2 patients
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with intervals of 48 hours and 40 hours, a fluorescent
result of brilliant and moderate intensity respectively
was obtained. The remainder all had lavage between 30
and 36 hours. Within the limits given above it does
not seem that the exact interval is critical, but to
avoid "false-positive" results it would seem unwise
to curtail the interval much below 30 hours, although
no direct evidence has been ascertained on this point.
Relation of Fluorescence Test to Cytological Examin¬
ation
In those 18 cases where routine cytological
examination after staining with Papanicolaou or
haematoxylin and eosin was performed, only on 4
occasions were the cytologists able to report
malignant cells definitely present in the gastric
lavage specimen. In 2 other cases they were
suspicious of atypical cells being malignant, and in
12 cases they reported no malignant cells to be seen.
The relationship of the fluorescent test results to




Positive It Negative Performed
Brilliant 8 3 1 0 4
Moderate 10 1 1 5 3
Weak 5 0 0 4 1
None 7 0 0 3 4
Total 4 2 12 12
Table 6. Relation of Fluorescent Test to Cytology
From this analysis there is the suggestion
that the more material being exfoliated from a tumour
the greater is the likelihood of routine cytology
being diagnostic and the more brilliant is the TC
fluorescent test. Nevertheless the results of cytology
with only 6 (33$) positive or suggestive results
compares badly with the 77$ success rate of the TC
fluorescence test in this series.
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SUMMARY OP RESULTS OP TO FLUORESCENT TEST
No characteristic fluorescence was found in
the resting juice of 24 patients with peptic ulcers,
nor in 5 patients with gastric malignancy who had not
received TC.
In 45 patients without gastric malignant
disease, who had received TC, there were only 2 weak
golden-yellow smears, both in apparently benign gastric
ulcers. Standard exfoliative cytological studies showed
no malignant cells.
Of 30 patients with gastric malignancy prepared
with TC, 23 (77$) gave a positive fluorescent test for
malignancy and 7 (23$) gave a negative test. The results
are analysed in relation to tumour differentiation, gross
type, mode of administration of TC, and interval from
discontinuing the drug to gastric lavage. Standard
exfoliative cytological examination for malignant cells
was performed in 18 cases from the gastric carcinoma
group and in only 6 instances (33$) were suspicious or
definite malignant cells seen.
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PART 2.
THE VALUE OP THE TETRACYCLINE FLUORESCESCI
TEST FOR GASTRIC CARCINOMA
Published Experience
Klinger & Kats (I960, 1961) administered TC
250 rag, t.d.s, for 5 days to 59 patients and performed
gastric lavage "before and 24 hours after stopping TC,
The eentrifuged deposit was dried and examined under
an ultraviolet lamp for the characteristic yellow
fluorescence of TC, In all patients before TC, the
deposit showed no fluorescence, whereas in 17 out of
18 patients with gastric carcinoma a positive test was
obtained with the demonstration of variable but definite
naked-eye yellow fluorescence, A negative test was
also obtained before and after TC in 41 controls (see
Table 9») Any free acid was neutralised to pH6 with
sodium bicarbonate solution, as they found that acid
quenches TC fluorescence,
A similar technique was employed by Kantor
(1961) and Berk & Kantor (1962) using DMTC as they
TABLE 9.
EXFOLIATIVE FLUORESCENT STUDIES II! GASTRIC CARCINOMA - SURVEY OF THE LITERATURE
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found the fluorescence of 150 rug. of this drug was
greater than that of 250 mg. of TC. All 10 cases
of gastric cancer showed a positive fluorescent test,
but there were 3 "false positives". In two of these
however it was suggested that the gastric ulcer was
"premalignsnt" because of raucosal atypism, and the
remaining "false positive" case was of a patient with
an unproven benign gastric ulcer, still unaer observ¬
ation, whose gf stric washings showed cells suspicious
of malignancy. These workers also stress the import¬
ance of adjusting the pH to between 6 and 7, and the
early examination of the smears from the gastric
lavage as soon as the specimen was dry.
It was following these two reports that my
own series was started, but since then there have been
many publications giving varying experience, so the
present series would still seem to have some
relevance.
Sherman et a!. (1963) next reported a
series of cases of gastric lavage for carcinoma
again showing a high (16/17) positive fluorescence,
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but they showed that the remaining "false-negative"
case on gross examination showed positive fluorescence
when the smear was examined with an ultraviolet
microscope. In their series they reported 64 controls
without gastric disease and 27 non-carcinomatous
gastric cases with negative fluorescence. There were,
however, 2 "false-positive" results, one from a
patient with hepatic cirrhosis and one from a patient
with a gastric adenomatous polyp which on microscopy
although benign, had areas of "cellular atypism"
corresponding to areas of fluorescence under the
ultraviolet microscope.
These studies seemed promising to these
first three groups of authors who felt that their
results indicated a useful method for the different¬
iation of carcinomatous and non-carcinomatous gastric
disease, whilst accepting some fallibility.
However, Aberle (1963ab) threw doubts on
the validity of the procedure. He examined 53
specimens of basal gastric secretions from 48 patients
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without prior administration of TC and without gastric
carcinoma or gastric ulcer, prepared the sediment in
the usual way by neutralisation, centrifuging and
allowing to dry and examined the smears, comparing
them with a freshly prepared known positive standard
under ultraviolet light. Positive fluorescence was
noted in 13 out of 53 specimens, and 6 of these
positive results were obtained from 13 specimens from
patients who had undergone gastric surgery. Aberle
(1963) also reported "false-positive" fluorescence in
7 of 19 tests in patients prepared with TC who had
benign gastric lesions, a "false-negative" result in
one or two cases of gastric carcinoma.
Berk (1963) rapidly answered these
criticisms of Aberle (1963ab), emphasising that the
latter had only studied a few patients after TC
administration and that of these only 2 had gastric
carcinomas. He quoted his current (1963) total of 38
patients with gastric carcinoma with a positive
fluorescence test of 87$ and 140 subjects with normal
stomachs or benign lesions of the stomach in whom only
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4$ "false-positive" results were obtained.
On the basis of his figures he felt that the
degree of accuracy was "of an acceptably high order".
Emphasis is placed by this author on the difficulty of
identifying the characteristic fluorescence of TC and
implies that inexperience in interpreting the presence
of characteristic fluorescence might account for the
unduly high proportion of false positive results in
benign gastric lesions and in basal secretions
reported by Aberle.
However, Hahn-Pederson et al» (1963)
reported very poor results with this test in a small
number of cases. Only 2 out of 6 cases of gastric
carcinoma showed fluorescence of dried deposit after
TC, whereas there were 7 false-positive results in 18
cases of peptic ulcer. They concluded that the TC
fluorescent test was not a satisfactory method for
differentiating between benign and malignant gastric
ulcers.
A small series of 5 cases of carcinoma and
8 proved benign lesions was reported by Klass (1963)
from Detroit and compared with Ms results of
exfoliative cytology on the same specimens. Whereas
his cytological results were always correct in these
small number of cases there were 3 "false-negative"
and 5 "false-positive" TC fluorescent results in these
two groups of malignant and benign cases respectively.
This author felt that the discrepancy in his results
as compared with other series was probably accounted
for by difficulties in examining the dried smear under
ultraviolet light. He points out that bile appears
yellow under ultraviolet light but does not fluoresce,
whereas impurities in the filter paper fluoresce a
brilliant whitish colour. He concluded that the test
was of no value as long as there was no more objective,
quantitative method for assessing the result of the
test.
In Columbia, Segura & Martinez (1963) using
the method of Berk (1961)with DMTC found that only
half of their 28 cases of carcinoma showed fluorescent
washings, but their results are invalid for in the
earlier cases of their study their technique was
faulty. From Mexico, Echeverria et al. (1963) report
successful experience with the test in all of 18 cases
of gastric carcinoma, but 2 malignant lymphomas gave
negative results. There were, however, in the control
group of 39 patients, 5 "false-positive" results of
which 3 were in gastric ulcers where atypical mucosal
changes were suggestive of pre-melignency. Four cases
were excluded because gastric lavage before DMTC showed
fluorescence, a finding similar to that of Aberle.
Slatopololsky (1963) from Cleveland, Ohio,
again using DMTC gave a good report with 3 out of 20
gastric carcinomas failing to give fluorescence and
only one control out of 60 giving "false-positive"
fluorescence. He found that three days treatment of
the patient with DMTC was sufficient to prepare some
of his patients and that a 24 hour gap was all that
was necessary to allow clearance of the drug from
normal body fluids.
In Italy experience seems to differ. Forni
(1963) reports poor results with only 9 out of 15
carcinomas and 8 out of 34 controls showing fluorescence.
However, Oria & Ferraris* (1964) experience was good
with 17 gastric tumours giving fluorescence and only
one negative result in a peptic ulcer with areas of
neoplastic change. They had one "false-positive"
result in 28 controls. Torino (1964) also found
encouraging results with only 1 carcinoma in 14
malignant cases not producing a fluorescent deposit.
Of the 30 controls, 3 gave fluorescence. It is of
interest that a lymphoma gave a negative test, as did
two of these tumours in Echeverria's (1963) series.
In contrast 4 sax^comas were found in these last two
Italian series to produce a fluorescent sediment.
From Sweden, Tomeniue & Lindkvist (1964)
using DMTC after the method of Berk & Kantor found
reasonably satisfactory results as did Hanngven &
Blomqvist whom they quote. These workers record 12
out of 15 positive tests in gastric malignancy, and
only one false positive result in 49 examinations of
benign gastric lesions.
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From Norway however Rugtveit & Hope (1964),
whilst obtaining comparable positive results in gastric
malignancy (17/18), found in their control group of 18
cases, mainly gastric ulcers, equal numbers of negative
and false-positive results. For this reason they
conclude that the test is of little value in different¬
iating between cancer and gastric ulcer. They also
showed fluorescence in the cut surface of gastric ulcers
and cancers, surprisingly enough not related necessarily
to the results of fluorescence of lavage specimens.
Worsley et al. (1963) in Montreal reported a
small series of 5 gastric carcinomas in which 3 were
positive on exfoliative cytology and 2 positive on
fluorescent testing. They felt that the test was
"inferior to good cytological techniques and had not
proved of great value", but it must be stressed that
their series was small.
From Russia, Kravchick (1964) supports the
value of the TC test, finding all 16 gastric carcinomas
produced TC fluorescence in the gastric lavage smears,
although there were 2 positive results out of 39 non-
malignant cases. In addition a preliminary test "before
TC never gave the characteristic fluorescence.
In 1964» Cummins et al. reported their
experience with the fluorescent test using the method
of Berk & K&ntor and comparing their results with those
obtained with exfoliative cytology using conventional
staining methods. Prom their series of 25 cases of
gastric malignant disease (including 1 leiomyosarcoma)
they had only 44$ positive result with fluorescence
but 64$ with gastric cytology. In 104 patients with
benign gastric lesions, there were 94$ negative
fluorescent tests for malignancy, but only 84$ were
definitely negative on cytologlcal grounds. They
suggest, as a possible explanation for false results,
retention of TC particles in the stomach by pyloric
obstruction, necrotic debris in benign ulcers,
ingestion of other fluorescent material, and malignant
lesions proximal to the stomach. Unlike Aberle (1963b)
they did not find fluorescence of the gastric sediment
before TC treatment. Their conclusions were that the
fluorescence test was "neither simple nor reliable".
Sandlow et al« (1963) and Sandlow & Kecheles
(1964ab) have published a large series of eases
including 35 gastric malignancy in whom they found
that the TO fluorescent test of gastric washings was
positive with an accuracy of 96$. In the 75 non-
ulcer controls, there were 7$ "false-positive" and
in 75 benign gastric ulcers 4$ "false-positive".
By repeating the gastric washings 60 hours post-TC
in all cases with positive results they have recently
reduced the number of "false-positives".
The latest cumulative results by the two
original advocates of the TC fluorescent test,
together with the results given above from Sandlow &
Kecheles (I964ab) constitute the three largest series
and all find the test of value with a fairly high rate
of diagnosis of gastric cancers and an acceptably low
rate of "false-positive" results in controls. Thus
Klinger, Arteaga & Katz (1964) from Chile with a
standard 5-day course of TC, 250 mg. t.d.s., obtained
fluorescence in the gastric deposit of 46 out of 73
carcinomas. Even though this detection rate of 63$
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is not very impressive they had only 1$ false results
in their non-malignant cases. In cases of pyloric
stenosis where gastric retention of the oral drug
could give fallacious results they use intramuscular
TC. Their experience of an abbreviated more intensive
course of TC (500 rag. q.d.s. for 2 days) and of OTC
would suggest that their original method and drug are
preferable.
Berk & Kantor (1963) from Detroit who have
been the advocates of DMTC in a standard regime of
150 mg. q.d.s. for 5 days, were equally impressed with
the test, obtaining positive fluorescence in all but 5
of 39 gastric carcinomas. A "false-positive" rate of
3$ seems acceptable.
The discrepancies between the published series
is disturbing and perhaps may be attributed to a failure
of technique as stressed by Berk & Kantor (1963) who
emphasise strict attention to detail if erroneous
results are to be minimised. It is of some interest
that they eluted material from the filter paper and were
able to demonstrate by chromatographic means that the
fluorophore has the same motility as unmodified TC.
Technique of the Tetracycline Fluorescent Test
Strict attention to detail in the performance
of the test is essential in order to minimise erroneous
resuits, and attention to the following points is
emphasised?-
1* Preparation of the Patient
As it seems probable that the intensity of
fluorescence is in part related to the individual
nature of the tumour and in part to the blood level
of TC achieved, it is essential that adequate amounts
of a TC drug be given. Berk & Kantor (1963) advocate
not less than 3*0 gm. of DMTC be given in divided
doses by mouth. Although they have shown that this
is an adequate preparation, on theoretical grounds
there is the possible danger of increasing the number
of false positive results because of the delayed renal
excretion and persistence of higher tissue levels,
especially if there is any degree of renal insufficiency.
For this reason many workers, notably Klinger,
Arteaga & Katz (1964), Lave continued to use TC as
originally advocated by them in I960, The dosage
originally used by these workers was 250 mg. TC orally
t.d.s. for 5 days, but it may be significant that this
total dose of 3,75 gm. gave a rather low diagnostic
rate of 63$ of 73 tumours. When they compressed their
TC into a total dosage of 4.0 gm. over 2 days their
diagnosis rate fell to an unaeceptably low figure of
23$ of 12 tumours, Sandlow & Kecheles (1964ab),
however, with the same concentrated regime obtained
53 positive diagnoses and their 2 negative results
included a linitis plastica without mucosal involve¬
ment and a case examined with a faulty technique.
My own results, coupled with those of Rravchik (1964)
and Sherman et al, (1963) would suggest that the
slightly higher dosage of 250 mg. q.d.s. for 5 days
(total 5,0 gm,) gives a reasonably high diagnosis
rate. On some occasions it may be necessary to
compress the TC regime so as to obtain quicker results.
In so far as a dosage of 500 mg. q.d.s. produces blood
levels of 4 ug./ml. in 3 or 4 days, whereas 250 mg.
q.d.s. takes 5 days to achieve that level, in theory
the higher dosage regime would seem to be satisfactory.
Certainly Sandlow & Hecheles (1964ab) found that a
total dose of 4.0 gm. over 2 dayB was highly satis¬
factory, and in ray own 10 cases prepared with 5*0 gm.
over 2$ days the results were also satisfactory.
The derivative OTC was tried by Klinger
et al. (1964) with poorer results, but the drug, DMTC,
has been tried by many workers following the example
of Berk & Kantor (1961). It appears that 150 mg.
DMTC gives equivalent blood levels to 250 mg. TC and
these workers advocated a dosage of 150 rag. DMTC
q.d.s. orally for 5 days with positive results in 87$
of 39 tumours, and only 3$ "false-positive* results
in benign diseases. Comparing all published reports
TC produced 76$ positive tumour results compared with
74$ for DMTC so there is no significant difference
between the two drugs in this respect. It might be
expected that DMTC would produce more false positive
results than TC by virtue of its higher plasma protein
binding and slower excretion. In fact comparison from
the collected literature gives If "false-positive"
results with TC and 4f with DMTC, although these
figures may be fallacious because of differing
techniques. If there is renal insufficiency, DMTC
will persist longer and might give more false
positive results than TC.
For very rapid preparation of the patient
or when there is any suggestion of failure of absorp¬
tion due to vomiting or gastric stasis, the drug must
be given by a parenteral route. Sandlow & Necheles
(1963) recommend that where more than a small amount
of clear secretion is found on initial aspiration,
the lavage should be cancelled or parenteral admin¬
istration of the drug be given before proceeding a
few days later. Intramuscular administration of TC
has been found by Klinger et al. (1964), Sherman
et al. (1963)» Sandlow & Necheles (1964) and Torino
(1964) to be a perfectly adequate method. The
dosage regimes varied from 600 to 1500 mg. spread
over 1 to 5 days, but insufficient details are given
by the authors for the optimum intramuscular regime
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to be assessed.
In my own series I did not use intramuscular
administration but, where parenteral administration was
essential, preferred a single intravenous drip over j? to
4 hours of 1000 mg. of TC as being quick and achieving
very high blood levels. In all 6 cases prepared by the
intravenous route the fluorescence was brilliant or
moderate so it would seem that this method gives good
results. In the literature the only authors to use
intravenous TC were Rugtveit & Hope (1964) in a dose
of 3000 mg. and, although their tumour diagnosis rate
was satisfactory in a small series, they were amongst
those who found a high percentage of "false-positive"
results.
In summary therefore the dosage schedules
which seem to be adequate for preparing the patient arej-
TC 250 mg, t.d.s. or q.d.s. orally for 5 days
TC 500 mg. q.d.s. orally for 2-k days
DMTC 150 mg. q.d.s. orally for 5 days
TC 250 mg. b.d. by intramuscular injection for 2 or
more days.
TC 1000 mg. by intravenous drip over -§- - 4 hours.
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2. Absorption of the Drug
The mechanical problems of absorption of TC
where there is pyloric stenosis or vomiting have already
been dealt with in the preceding section. More subtle
influences may lead to poor absorption of the drug.
Milk, railk products and aluminium hydroxide are frequently
being given to patients with dyspeptic symptoms and these
factors can impair absorption of the TC drugs (Scheiner
& Altemeir, 1962). After a single oral dose of 300 mg.
DMTC an average peak concentration of 2.08 ugm. per ml.
is reached in 3 to 6 hours, whereas if milk or cheese
are eaten at the same time, the peak level is about
0.6 ugxa. per ml. Similar effects with the other
tetracyclines have been shown by Martin <§- Harper (1959)
who demonstrated that the mechanism was probably the
formation of a calcium caseinate complex with TC drugs.
With aluminium hydroxide gel even more marked reduction
in blood levels of TC has been observed by Waisbren &
Hueckel (1950), perhaps due to absorption of the
antibiotic on to the gel.
Whilst the patient is being prepared with
oral TC or DMTC for the gastric lavage, no aluminium
hydroxide should he given and diet should not be
supplemented with milk or milk products.
3. Interval between stopping the drug and lavage
The importance of allowing an adequate period
for clearance of the drug from normal tissues so as to
avoid false positive results in benign conditions must
be stressed. Although some workers have obtained
perfectly good results with a 24 hours interval, as
there is still a trace of TC or DMTC circulating at
this time it would seem wise to allow a minimum
period of 30 hours before lavage.
4. The necessity for vigorous lavage
Fluorescence of the gastric sediment depends
on the exfoliation of cells from malignant tissue.
Vigorous lavage of the stomach, using a large syringe
with the patient placed in several positions and
simultaneous massage of the stomach through the
abdominal wall are important in achieving adequate
material for examination. Whereas for exfoliative
cytology degenerate cells are unsuitable for
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examination, in the TC fluorescence test the overnight
gastric residue should not be discarded as it may
contain fluorescent material. It has been found that
about half-an-hour needs to be spent in performing an
adequate lavage.
5. Neutralisation of the lavage fluid
TC fluorescence is quenched by a high
concentration of hydrogen ions (Berk & Kantor, 1962).
The lavage fluid must be neutralised, if necessary, to
a pH of about 7 using sodium bicarbonate, or if preferred
a buffered acetate lavage fluid may be used, is fluoresc¬
es® in vitro of TC is even greater at a pK of 9# Kohn
(1961) was trying this degree of alkalinisstion but has
not reported his results,
6. The time of examination under ultraviolet light
The sediment must be allowed to dry before
scrutiny as the hydration shell of TC quenches fluoresc¬
ence. As fluorescence progressively decreases with time
the ultraviolet examination must be performed as soon as
possible and not longer than 6 hours after lavage.
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7. Misleading results from tumours elsewhere
The possibility of fluorescent material
deriving from malignant disease in the lungs, mouth,
pharynx or oesophagus being swallowed by the patient
and giving a positive result on gastric lavage must
be considered# It is indeed possible that similar
fluorescent exfoliation from tumours of the pancreas
or bile passages could regurgitate into the stomach
giving confusion to the site of the primary tumour.
Cummins et al« (1964) report a patient with
questionable fluorescence on gastric lavage who had
a carcinoma of trachea eroding into the oesophagus
and malignant cells were to be found in the gastric
washings. Bernhardt et al. (1963) have demonstrated
malignant cells from bronchogenic carcinomas in 6
out of 10 patients. Colmore (1964) prepared 15
patients with bronchogenic carcinoma with 5.0 gnu TC
and after a 48-hour interval performed gastric lavage.
He obtained 12 fluorescent results as compared v/ith
1 such result in 15 controls.
8• Identification of TC fluorescence
To be interpreted as a positive test, the
dried sediment should be of a bright golden-yellow
colour which is quite distinctive and, with experience,
easily identified. A dried smear of dilute drug
should be used as a standard for comparison to avoid
confusion with the commonly seen white fluorescence or
dull yellow bile colour.
The major criticism levelled at the TC
fluorescence test is its lack of objectivity in
identifying TC fluorescence and it is probably this
fact which has led to some poor results, especially in
inexperienced hands. In an effort to give an. objective
interpretation of the test Socci et al. (1964) have
used a photographic method to compare the colour of the
fluorescence of a pipette of gsstric sediment with that
of a standard tube of TC. They claim that their colour
photography gives absolutely true colours allowing
objective interpretation and reporting, but of course
the processing of colour film takes time and once again
the comparison is subjective.
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A more scientific approach has been reported
in the last few months by Berk et al. (1965)# They
devised two new extraction techniques using paper
chromatography for specific identification of DMTC and
column chromatography with fluoroiaetric analysis to
measure the quantity present. In this preliminary
communication they report that although DMTC was not
evident by paper chromatography in the gastric sediment
of normal persons pre-treated with DMTC, a minute
amount could be found in 5 out of 6 normals by the
second technique. The quantity of DMTC was considerably
less than in his two eases of gastric cancer and they
suggest that simple paper chromatography may serve as
an objective screening test. If this is positive then
the more complex procedure of column chromatography and
f'luorometric analysis may be used as a second stage to
determine the actual quantity of DMTC present. A large
number of tumours and benign cases will have to be
examined to determine the limits of the test, but this
objective approach would seem to offer great
possibilities for the future.
147
Discussion
In the preceding description of the reported
series, many conflicting opinions are given as to the
value of the TC fluorescent test in the diagnosis of
gastric malignancy. With such dissension an
explanation must be sought for the differing evalu¬
ations in the literature.
She criticisms of Aberle (1963ab) were the
most vigorous as he found that out of 53 samples of
gastric ;}uice examined without the exhibition of TC, as
many as 13 specimens showed yellow fluorescence which
he could not differentiate from that of TC. If indeed
this reported false fluorescence were correct, the TC
fluorescent test would have no validity whatsoever.
From the IS published series however he receives
support for this finding only from Echeverria et al.
(1963) who found apparently typical fluorescence in
4 cases out of 63 examined before TC.
In contrast Klinger, Arteaga & Katz (1964)
with 59 cases, Forni (1963) with 15 cases, Cummins
et al. (1964) with 61 cases, Kravchiek (1964) with 55
cases, and the present series with 17 cases, from which
gastric ;juice was examined before TC, showed no typical
golden-yellow fluorescence at all. Thus in the 207
cases examined by these workers, no false fluorescence
could be found before TC, whereas the two other groups
found 17 in 116 examinations. One suspects that the
difference lies in the criteria for visual appraisal
of the smears.
If one analyses the overall results from the
18 published series and my own there were 75 "false-
positive" fluorescent results (6.5$) in non-malignant
controls after TC or DMTC, compared with a total of
1,073 negative results. It is of some interest that in
the 75 "false-positive" results are included 6 cases
where there was "mucosal atypiem" either in gastric
ulcers or in a polyp suggesting a possibly early or
pre-malignant state. If the results of Aberle (1963a)
and Echeverria et al. (1963) are excluded on the
grounds that their ability to recognise true TC
fluorescence is in doubt, the number of "false-
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positive" results falls to 63 out of 1,090 examin¬
ations, i.e., 5.8$.
The TO fluorescent test was positive in 331
cases from the collected series of gastric malignancy,
including 8 cases of gastric sarcoma, with negative
fluorescence in 113 cases of which 5 were gastric
lymphomas. Thus the overall diagnosis rate was 74.5^
with a failure of diagnosis in 25.5$. Again excluding
the two dissident authors who found fluorescence in
basal secretions, the diagnosis rate for gastric
malignancy becomes 73.9^.
It is of interest to analyse the results of
the larger series of cases where experience in the
technique would be greater end when the recognition
of TC fluorescence would presumably be more accurate.
Thus taking all groups' experience where the numbers
tested exceeded 50 patients, and excluding the results
of Segura &■ Martinez (1963) who in their early cases
used a poor technique, we find that 76.8^- of malignant
cases were diagnosed correctly and, perhaps more
significantly, the "false-positive" results in benign
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patients fall to 2.9$ of 887 cases.
Thus it would appear that the diagnosis can
be made in about three-quarters of patients with gastric
malignant disease and that there is a fallacious
positive fluorescent result in 2.9 to 5»8$ of benign
cases, the better results being obtained by the more
experienced workers. This compares with 77$ positive
results and 4$ "false-positive" results in my own series.
These results would seem to be extremely
encouraging, although one does not know what proportion
of the tumours tested were at an advanced stage where
diagnosis by other means, such as barium studies,
gastroscopy or exfoliative cytology v/ould give
comparable or better results. The two main problems
in the diagnosis of gastric carcinoma are the early
diagnosis and the differentiation of benign from
malignant lesions without resort to laparotomy. Mo
evidence can be quoted for the value of the TC
fluorescent test in early diagnosis. It would seem,
however, that at least in the later stages the test
is of value.
A comparison of the diagnostic accuracy of
cytology, radiology and endoscopy in particular
relation to that of the TC fluorescent test can only
be made from a study of different series in the
literature. There is considerable variation in the
skill, care and experience of the cytologist,
radiologist and endoscopist and there is a tendency
for only those workers with vast experience and
enthusiasm to report their work, which in general
will give a much better diagnosis rate than is in
fact obtained in routine work in hospitals throughout
the world,
A useful comparison is made by Kenning,
Witte and Bressel (1964) who obtained a diagnostic
accuracy of 73.5$ with cytology, 89.4$ with radiology
and 72,7$ with endoscopy in a large series of
oesophageal and gastric malignant tumours, the best
figures being obtained from the oesophagus and cardia.
Reviewing the literature of many authors with differing
methods of inducing gastric exfoliation, rinsing,
dabbing, balloon, nylon knots, etc., no ma^or
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difference in cytological results can be shown, end
the diagnostic accuracy in 3480 cases was 69.8$. It
must be stressed that these exfoliative cytology results
tend to come from special units with highly trained
experienced cytologiets and that there is a variation
in successful diagnosis from about 50$' to over 90$
(Raskin et al» 1959)* Doubtless in less expert hands
the diagnosis rate for gastric cytology will fall
below 50$.
In a survey of the literature for comparison
of cytology and radiology by Henning et al. (1964), of
858 oesophageal and gastric malignant tumours, 72.3$
were correctly diagnosed by X-ray examination compared
with 80.8$ cytological diagnosis. In a similar
collection of 67 cases, 65.7$ were diagnosed on
endoscopy.
It will be seen therefore that the overall
diagnosis of malignancy of the stomach by the TC
fluorescent test, from the collected series, is 74.5$
which compares well with that of cytology (69.8$),
radiology (72.3$) and endoscopy (65.7$) in the
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collected series of malignant tumours of stomach and
oesophagus.
However, in the assessment of any technique
for diagnosis of malignancy, the number of positive
diagnoses must be assessed in relation to the number
of fallacious or "false-positive" results with benign
conditions. Again Henning et al. (1964) have produced
most valuable collected figures from the literature.
The comparison of false positive results in 113 cases
of benign disease was 1.5$ for exfoliative cytology
and 4.4$ for radiology. In 178 cases a false
diagnosis of malignant disease was made in 2.8$ by
gastroscopy and oesophagoscopy. One of the difficulties
in assessing collected series, particularly in cytology,
is that in the literature it is not always clear what
was a questionable and what was a probably positive
misinterpretation, so these results may be slightly
over-optimistic. In Henning*e own series, doubtful
reports were excluded and only the highly probable and
definite false positive cases included. In 153 patients
with benign disease, a fallacious diagnosis was reached
in between 3 and 5 per cent for each of the three
diagnostic procedures. With reference only to cyto-
logical "false-positive" results in the literature
from 1947 - 1962 of 7893 benign cases examined, an
incorrect malignant diagnosis was made in 1.9^f
although the variation of different authors was
from 4.7$ to zero.
It will be seen therefore that in this
respect the TC fluorescent test is not so accurate,
with a false positive result of 5,8$ from the
collected series although only 2,9$ from the more
experienced workers and 4$ in my own series.
One may assume that only rarely will the
detection of a malignant tumour of the stomach be
missed provided all three diagnostic procedures are
performed regultrly and simultaneously in every case
by highly skilled experts. Unfortunately such
highly-trained specialists are not always to be
found especially in the smaller hospitals and herein
may well lie at least part of the value of the TC
fluorescent test. It would also seem reasonable to
advocate its use with exfoliative cytology, as the
gastric lavage conveniently provides material for
examination under the ultraviolet lamp and after
staining for microscopic examination for malignant
cells.
The value of cytology and perhaps of the
TC fluorescence test lies mainly in the clarification
of radiologically or gastroscopically questionable
findings. In rare cases cytology has been
responsible for tumour diagnosis in the absence of
other evidence. Schade (1964), particularly, has
contributed to the early diagnosis of in situ
carcinomas by cytology. As he says, "only the
diagnosis of a carcinoma in situ counts as a success
for cytology", for the radiologlcally or endoscopic-
ally visible gastric carcinoma is unlikely to have
the prospect of permanent cure by surgical excision.
The screening of selected popul tions by gastric
lavage is a possible approach to the problem of
early diagnosis of carcinoma of the stomach. The
association of gastric cancer with pernicious anaemia
is generally accepted, the incidence being estimated
to be 3 to 20 times that in the general population
(Hitchcock et al. 1957, Mosbech & Videbaek, 1950).
The frequency of gastric cancer in achlorhydric or
hypochlorhydric patients is 3 to 4 times that of
patients with normal acid secretions (Hitchcock et al.
1957). Any screening programmes therefore would
logically involve patients with pernicious anaemia
and elderly persons, especially men, who are achlor¬
hydric or hypochlorhydric. Although the experience of
MacDonald et al. (1964) in such a selected group, was
disappointing in that the carcinomas discovered were
also demonstrable by barium studies, future experience
may show such an approach is ?/orthwhile in discovering
early in situ carcinoma.
The evidence for possible early detection of
cancer by the TC fluorescence test is extremely scanty
and certainly in my own series no such evidence can be
deduced. We are certainly watching the two cases with
negative cytology, apparently benign gastric ulcers
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but weak positive fluorescence, most carefully to see
if there is any suggestion of overt carcinoma# In the
literature the extent of the radiological changes in
the carcinomatous group is seldom mentioned, and
certainly in my own cases practically all were obvious
on barium meal# Nevertheless Berk & Kantor (1963)
report "mucosal atypism" in gastric ulcers in 2 of
their 4 apparently "false-positive" results, and
Sherman et al. (1963) report one of their 2 "false-
positive" results had "focal atypism" in an adenomatous
polyp. Similarly Echeverria et al. (1963) found in 3
of their 5 "false-positive" cases, gastric ulcers
"with atypical mucosal changes suggestive of pre-
malignancy". On the other hand Oria & Ferraris (1964)
had their only false negative result in a peptic ulcer
with areas of neoplastic change. It may be that the
combination of exfoliative cytology and the (DC
fluorescence test will prove useful in any screening
programme #
PART 3.
OTHER DIAGNOSTIC APPLICATIONS OP TETRACYCLINE
FLUORESCENCE IN TUMOURS
The bulk of the literature on the diagnostic
applications of tumour fluorescence with TC deals with
gastric malignancy* but the same principles may be
utilised for other malignant disease. My own
experience in other situations is very limited and will
be mentioned in the relevant sections.
A. Sputum. The possibility of fluorescent malignant
material from the lungs, pharynx or oesophagus being
found in the gastric lavage material has already been
mentioned as a source of possible confusion in
determining the site of malignancy.
The work of Colmore (1964) using a standard
method of TC preparation and obtaining 12 fluorescent
gastric lavage results in 15 patients with bronchogenic
carcinoma, suggests a diagnostic method for patients
unable to produce specimens of sputum for examination.
Slatopololsky (1963) examined the sputum of
5 patients with bronchogenic carcinoma after a 5-day
course of 33MTC and an interval of 48 hours. He found
fluorescence in the sputum smears in 4 of these
patients. Similarly, Sandlow & Necheles (1964)
mention 2 positive sputum smears in bronchogenic
carcinoma.
The only detailed study has been by
Hiduchenko (1965) who prepared his patients with
4.0 gnu TO over 4 days and allowed a 30 to 36 hour
interval before obtaining and preparing the sputum
by adjusting the pH to between 7 and 8. The sputum
was then smeared and allowed to dry overnight but a
defect of the technique was that the smears were not
examined for fluorescence until 24 hours had elapsed.
Smears were examined before the course of TG and 5
patients were excluded because of the presence of
yellow fluorescence but 3 of these had had TC earlier.
There was also one patient with carcinoma and one
with tuberculosis. Of 19 bronchogenic carcinomas
examined with this technique 16 were positive, 3
equivocal, but none negative. Of 22 other pulmonary
diseases, 17 were negative, 2 equivocal and 3 showed
definite yellow fluorescence, of which one was in
renal failure arid would thus probably have persistent
high circulating TC blood levels. It appears therefore
that although a high diagnosis rate of bronchogenic
carcinoma can be obtained from fluorescent sputum
smears, there are apparent "false positive" results.
My own experience with the technique is with
only 6 cases, each of whom had a bronchogenic carcinoma,
prepared with 5*0 gm. TC and examined after an interval
of 36 hours. The sputum was simply smeared on glass
slides and there was no adjustment of pH. In 4 of the
6 cases, there were flecks of characteristic
fluorescence on the smears. In 6 patients with non-
malignant pulmonary disease, there was no golden-
yellow fluorescence, after a similar preparation with
TC. Exfoliative cytology was positive in 3 of the 6
carcinomas and there was one carcinoma which showed
fluorescence but a negative cytology on 3 occasions.
Bronchial aspirate at bronchoscopy was
examined in only 1 patient with bronchogenic
carcinoma who had been prepared with TC and the smear
showed an occasional fleck of fluorescence and was
cytologically positive.
Smears were taken on to glass slides from
4 bronchial biopsies of carcinoma and in 3 instances a
positive fluorescent result was obtained.
The total number of cases of carcinoma of
lung so far reported are insufficient for a true
evaluation of the TC technique to be made. Many
varying reports on the value of exfoliative cytology
have been published mainly using the Papanicolaou
method of staining, and a differing number of sputum
examinations• In the best hands where scrupulous
attention to detail is carried out and multiple sputum
examinations are made, results may be as high as 79$
positive diagnosis with only occasional erroneous
results (Koss et al. 1964). It is emphasised however
that in less skilled hands and with fewer specimens
examined, results will be much poorer. As with gastric
carcinoma, the shortage of specially trained patholo¬
gists and technicians indicates the need for a simpler
test. Perhaps the TC fluorescent test on sputum will
prove of some value in conjunction with cytology or
where such facilities are lacking.
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B» Duodenal Drainage. Cytolcgical diagnostic
procedures of malignant tumours in the region of the
duodenum have not "been widely practiced in this
country and I have no experience of the TC fluoresc¬
ence test on duodenal drainage material, This
technique has been used by Sandlow et al, (1964ab)
who prepared their cases with TC, allowed a 36 hour
interval and then performed duodenal intubation with
secretin stimulation. In 7 cases of pancreatic
carcinoma they obtained typical TC fluorescence, but
none in 6 cases of chronic pancreatitis and 12 normal
controls, Slatopololsky (1963) mentioned that with a
similar technique but using "Urecholine" (bethanecol
chloride) as pancreatic stimulus, he obtained 2
fluorescent results in 3 carcinomas of the pancreas,
and in a patient with a hepatoma as well.
An analysis of the literature by Kenning
et al. (1964) revealed a cytological diagnosis rate
of 63,5$ of 181 cases with 2,8$ false positive results.
However few centres in this country practice this
technique of diagnosis in this difficult area for
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tumour detection. The TC fluorescent test has only
been tried in the few cases reported above, but where
duodenal intubation and pancreatic stimulation is being
performed cytologieal examination could well be
supplemented by the TC fluorescent test.
C. Serous Effusions. Effusions in the 3 principal
serous cavities, the pleura, the pericardium and the
peritoneum, due to malignant diseases have been examined
by the technique of the TC fluorescent test in a few
cases.
Of the 4 pleural effusions due to carcinoma
of the bronchus, prepared with a 5-day course of TC
250 rn.g. q.doS. and allowed an interval of 36 hours
before aspiration, 2 cases demonstrated bright golden-
yellow fluorescent particles on the dried smear. In
both cases exfoliative cytological examination gave
suspicious results for neoplastic cells. On the other
hand there were no fluorescent particles in the fluid
from 2 cases of heart failure, 2 cases of pneumonia,
and 1 case of pulmonary embolism. There was, however,
in 2 of these non-malignant cases a very faint rim of
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powdery golden-yellow fluorescence at the edge of the
dried smear of the centrii'uged fluid, although no
fluorescent particles in the cellular debris, which
would suggest that TC may be retained in serous
efiusions longer than in the blood stream.
In 3 patients with ascites due to portal
cirrhosis and one clue to heart failure, the same
faint powdery ring could be seen at the edge of the
smear in one cirrhotic case, although the debris
showed no fluorescence. Two patients with ovarian
carcinomatous ascites were examined by the same
technique and in one of these there were distinct
particles of moderate fluorescence in the deposit.
Sandlow & Necheles (1964ab) report 12
malignant pleural effusions all showing fluorescence
after preparation with TC, but 12 benign effusions,
due to infection and heart failure, showed none.
The same authors report all 12 malignant ascites
positive, and 12 benign ascites due to cirrhosis and
heart failure as showing no fluorescence. Cummins et al.
(1964) mention a false positive result in cirrhosis but
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5 negative results in other cirrhotics, and a
negative test in a patient with hepatic metastases.
These results of the TC test need verification,
but as there is some difficulty in the cytological
evaluation of effusions because of misinterpretation
of mesothelial cells, there would seem to be an
indication for a combination of the two techniques.
In comparison with the fluorescent results given above
we may note a diagnostic accuracy for cytology of 87$
in pleural and pericardial fluids quoted by Grunze
(1964) with 2$ false positive results, although haylor
6 Schmidt (1964) claim only 54$ decisively positive
malignant diagnoses from serous exfusions,
J). Urine and Bladder. Only one case of urinary tract
malignancy, a hypernephroma, has been reported by
Slatopololsky as showing TC fluorescence in a dried
smear of urinary sediment. Whitmore (1965) at a
lecture to the Royal College of Surgeons in London
stated that he had tried, in 42 patients with urinary
tract malignancy, a modified TC fluorescence using
alkalinisation and millipore filtration but had
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abandoned the procedure "as not being a useful
screening test".
Direct scrutiny of the bladder using a
fibre-optic ultraviolet eystoscope was described at the
same lecture (1965) with an increase in the number of
cases previously published (Whitnore et al. 1964).
They used oral TC 1.0 gm. daily for 2 to 6 days, an
interval of 12 to 72 hours being allowed for the urine
end normal tissues to be free of the drug. Out of a
total of 38 bladder carcinomas, 31 showed fluorescence
on ultraviolet cystoscopy and 2 were equivocal. The
most striking feature of their report was that 8 out
of 10 tumours were carcinomas in situ which were not
obvious with ordinary light cystoscopy. This of
course opens up an important aspect of TC fluorescence
in the search for the early bladder carcinoma in
populations at high risk, for example workers in the
rubber industry, as a further step in exfoliative
cytology screening programmes. In addition the
technique may be used to identify the extent of
spread and the presence of other early neoplastic
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lesions in patients with known bladder tumours. A
point, however, which must be borne in mind is that
calcareous deposits in the bladder also fluoresce
(Barlow, 1965)•
E. Colonic Washings. The only work reported on TC
fluorescence in colonic washings is by Carter et al.
(1962) who prepared their patients with 1500 mg. of
TC by intravenous drip on 5 successive days. After an
interval of 24 hours colonic lavage was performed until
the return was free from particulate matter. A one-
litre normal saline enema was given and when returned
the fluid was prepared as for gastric smears. Of 16
colonic washings, 7 fluorescent results were subsequently
shown to be from colonic carcinomas, one non-fluorescent
result from a carcinoma caecum, and one fluorescent
result from a patient who died shortly after of acute
pancreatitis. The other non-malignant colonic lesions
showed no fluorescence.
Lavage and cytology can account for a larger
percentage of early diagnoses and five-year survivals
in cancer of the colon than in tumours of
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the upper alimentary tract (Raskin & Pleticka, 1964)
It is therefore paradoxical that colonic cytology has
attracted much less support as a diagnostic procedure
than gastric cytology. The above authors' diagnostic
accuracy was extremely high with only 3*7$ of
carcinomas undetected, 2.8$ "false- positive" results
and 8$ unsatisfactory examinations in a total of 569
patients including 77 carcinomas beyond the reach of
the sigmoidoscope. No other laboratory in the world
can rival these results, but the figures show the degree
of accuracy of colonic cytology which can be achieved
in the best hands. The reason for the infrequency of
utilisation of the technique is probably the difficulty
of performing the test well. Nevertheless, to
supplement exfoliative cytology with a TC fluorescent
test would seem reasonable in order to obtain the
maximum information from this tedious and rather
unpleasant diagnostic procedure.
£kin. lipnik (1963) outlines a screening test for
malignant conditions of the skin by applying a solution
of 1$ DMTC with 0.1$ ey&nocobalamine directly to the
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lesion. A challenge solution of 4.9$ trichloracetic
acid is then applied to the tumour and if the test is
positive, the yellow-green fluorescence must remain
within the crusts of the tumour tissue for 10 seconds.
He noted a bright yellowish green fluorescence in 68
of 75 malignant and premalignant lesions including
basal cell epitheliomas, squamous cell carcinomas and
certain senile keratoses. Of 191 benign tumours
tested, 186 gave a negative result.
However, Burrows (1964) was unable to confirm
these good figures, for he obtained 43$ false negative
results in 42 malignant lesions, and 54$ false positive
results in 37 benign lesions.
The principle of the test seems somewhat
dubious in so far as the speed of disappearance of the
fluorescence with the acid must depend on the rate and
depth of penetration of the lesion, both by the TC and
by the acid.
That malignant lesions of the skin do show
persistent fluorescence when TC is administered
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systemically has certainly been shovm by myself to
occur (see Table 2., Appendix 2.), but no topical
applications were made* It seems doubtful if there is
any important place in skin tumour diagnosis for TC, as
any crusts or sloughs, because of their absent blood
supply, may show fluorescence until separation occurs,
and indeed Mustakallio (1962) suggested that TC
fluorescence might delineate the extent of necrotic
superficial injuries.
G. Biopsy Material. The suggestion has been made by
Takayama et al. (1964) that the phenomenon of TC
localisation in tumours should be utilised as a
substitute for frozen-section examination in the
operating theatre as the gross fluorescent examination
takes 1 or 2 minutes as opposed to 15 minutes for
frozen section. They administered 500 mg. of TC by
intravenous drip twice daily for 4 days with an
interval of only 12 hours before operation. The
intravenous route was chosen to achieve a high blood
level of 15 ugm. per ml. All 8 of their breast cancers
showed typical fluorescence as did 2 gastric cancers
and 2 renal cancers, They contrast the characteristic
light yellow fluorescence of tumours with the extremely
vivid yellow fluorescence of "panniculus adiposus" and
the autofluoreseence of 4 benign tumours, 3 cases of
mestopsthia, and one of chronic interstitial mastitis.
The number of cases is certainly not large enough for
them to advocate the widespread substitution of ultra¬
violet examination for frozen-section examination,
unless such facilities are unobtainable. Even under
those conditions one would hesitate to adopt their
idea as in breast lesions, where frozen-section is
most often required, weak fluorescence was demonstrated
in my cases on the lining of cysts and in one case
where radiotherapy had ill-advisably been given for
inflammatory disease.
One might, perhaps, utilise TC fluorescence
in the darkened operating theatre to delineate the
extent of a tumour, but within the abdominal cavity
or where there is fat the dull-yellow autofluorescsenee
of fat might well be confusing. In any case as
ultraviolet light only penetrates for 1 mm, into
tissues, the tumour would need to be cut across before
its extent could be seen« In bone tumours the
fluorescent aspect might be utilised as mentioned by
Bailey & levin (1961) who found it of help in one
excision of osteogenic sarcoma but the autofluorescence
of fat in the marrow may be a source of error and
indeed led these authors to amputate higher than was
necessary in one patient.
SECTION V
POSSIBLE THERAPEUTIC IMPLICATIONS OF TETRACYCLINE
LOCALISATION IN TUMOURS
INFLUENCE OF ANTIBIOTICS ON TUMOUR GROWTH
The possible relationship of tumour growth
and the uptake of antibiotics has been the subject of
sporadic reports in the literature, with differing
conclusions# Sokoloff & Eddy (1951ab) showed that
CTC promoted the growth of certain experimental
tumours but could also induce regression of others.
Gumiael & Luhrs (1953) noticed an increase in
experimental tumour growth during administration of
chloramphenicol, penicillin and TC. On the other
hand, several groups working with a variety of
animal tumours could discern no appreciable effects
with CTC, TC, or OTC. (Golaman, 1951? Ambrus et al..
1953; Koga, 1954; Sugiura, 1959).
In human malignant disease, Ayre (1951)
reported a regression in carcinoma in situ of the
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cervix in 6 patients being given CTC« A good effect
was reported by B&teman et al, (1952, 1953, 1955) in
several carcinomas, but these workers changed their
minds as their observations progressed, Goldman (1951)
reported no noticeable alteration in the clinical
course of patients v/ith Hodgkin's disease as a result
of administration of TC,
As a result of his clinical observations and
of extensive animal experiments, Uemura (1964)
concludes that although some antibiotics may occasion¬
ally produce either enhanced or inhibited growth in a
malignant tumour, most of the factors regulating their
growth are probably beyond the reach of bacteriostatics,
so that their influence is extremely weak and of no
clinical importance,
RADIOACTIVE IS0TOPE—LABELLED TETRACYCLINE
The diagnostic and therapeutic possibilities
of isotope-labelled TC have stimulated much interest
throughout the world in relation to tumour uptake of
the drug. Unfortunately neither the Radiochemical Centre
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at Amersham nor the major drug manufacturers of TC
have been able to provide me with an isotope-labelled
TC for use in animal experiments on uptake and therapy
of tumours, so no personal work has been possible in
this field.
Various radioactive Isotopes can be incorp¬
orated into the TC drugs, Snell et al, (1955)
labelled OTC with radioactive carbon, C"^, using bio-
1J
synthetic methods with a substrate containing C -
labelled sodium acetate. Using similar methods Miller
et al, (1956) were able to incorporate into CTC,
The first practical application of radioactive
TC was by Andre (1956) who prepared tritium-labelled TC
by substitution of tritium at the 10-position using
platinum oxide as a catalyst. With his stable compound
he studied the distribution of the drug, in experimental
animals using autoradiography, Takesue (I960) used the
same compound to assay serum levels and found a good
correlation with microbiological methods, Tritinted TC
was also used by Bakay (1962) to study the dynamics of
the drug in relation to meningitis and confirmed that
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although the blood-brain harrier is almost impermeable
to TO at the normal therapeutic levels, the barrier
readily breaks down in meningitis or brain abcess.
The first report in relation to tumours was
by Klavka & Buyske (I960), using the isotope l131
substitution into 7-iodo-6-deoxytetracyeline prepared
by their co-workers (Soothe et al.. I960).
Unfortunately, Elavka & Buyske found a lack of
selectivity of the drug in a dose of 0.015 mg. per gm.
for tumour tissue in dogs with spontaneous mammary
tumours, with maximum concentration at first in the
liver vfhich contained twice as much as the tumour and
the kidney, and very much more than muscle or bone.
After 24 hours the differences were much less
pronounced. Similar lack of selectivity for tumours
was found in mice with spontaneous mammary carcinomas.
However MeCleay et al. (I960) describe
briefly their studies with l131-lsbelled TC in a larger
dose of 0.25 mg. per gm. on mice with C5H spontaneous
mammary tumours. Scintillometer studies showed
localisation of radioactivity in the tumour. In a
1*51
higher dosage of 3 mg» per gm.» 1 -TC produced a
definite necrosis of the tuiaour with survival for the
duration of the study of 40 days, whereas tumour-
bearing mice not given the radioactive drug survived
for no longer than 20 days. No radiation effects
were observed in any other organ, but Mcheay (1962)
in a personal communication comments that the concen¬
tration of the drug in the liver is a complicating
factor in pursuing this line of research towards the
problem of human cancer. McLeay's initial report was
followed by one from himself and co-workers (Dunn et al.
I960). Sodium iodide was used to block thyroid uptake
1"31
in rodents before the 1 derivative was administered,
In this study in normal rooents, bone appeared to have
the highest uptake but the liver had a very variable
specific activity. In mice with spontaneous mammary
tumours, tuiaour tissue usually had the highest
activity, but there was variation of uptake compared
with bone and liver,
She same group of workers (Eskelson et al.,
1963) synthesised N-(4 radioiodopyrazole-methyl)-
tetracycline and studied its distribution in mice with
tumours. The compound was found to accumulate in the
liver of mice and dogs, but not in the mouse tumours to
anything like the same degree. They then compared the
distribution with that of 9-radioiodo-6-deoxy-6-demethyl
tetracycline. Because of large variations in tumour
uptake they were unable to draw any significant con¬
clusions beyond the suggestion that mouse tumours have
a preferential uptake for the non-amide substituted
compound, although still small in relation to that of
the liver over a 96-hour period. One wonders about the
stability of the compounds for the mice, which had not
been pretreated with iodide, showed a high uptake in
the thyroid gland.
This seems to be all the work which has been
done on isotope-labelled TG in relation to tumours and
it seems a great pity that the initial report with the
doubling of life-span and necrosis of tumours in mice
has not been investigated further with other substituted
compounds and with other tumours. An alternative
approach was mentioned by Phillips et al. (I960) who
had succeeded in conjugating a boronated TC compound
(tetracycline boronic acid) which was being studied
in animal tumours from the aspect of ultimate neutron-
cajture therapy. Their preliminary observations
indicated that the administration of this compound
permitted deposition of fissionable material (boron)
in cancer ti:sue, which could then be exposed to a
neutron beam• Ho further reports appear to have
been published cr this subject.
CYTOTOXIC AOMT CO&BIHAfIOH WITH TBTBACYCLIK3S
An alternative approach to cancer therapy in
this context i© by preparing © stable combination of
TC with a cytotoxic agent. A IC mustard compound has
been prepared by Kaplan et al. (1965) by conjugating
- (^"^-dichloroaiethylamine hydrochloride (nor HUg) witl
TC. They tested the compound on mice with spontaneous
tumours and showed some antitumour activity, although
whether the mustard compound was released mostly in the
injection solution, in the animals* bloodstream, or at
the neoplastic eell was not shown.
SUM! ARY
The historical aspects and current theory
of fluorescence have been described with reference to
this property of the TC drugs demonstrable by ultra¬
violet light.
The entire literature, relating to the
characteristic golden-yellow fluorescence induced in
malignant tumours by the TC's, has been reviewed.
The nature of the fluorophore and its fixation in
tumours, bone and other tissues has been discussed
with the role of calcium chelation being emphasised.
To verify and examine this property of
tumours, a study of 40 cases has been made with the
demonstration of typical fluorescence in 90?<< of
malignant neoplasms after the prior administration
of TC, Tumour-type and histological differentiation
does not determine the fluorescent intensity, which
is in part related to the TC blood levels achieved.
Occasional benign lesions showed faint fluorescence
after TC,
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Exfoliation of fluorescent material has "been
studied with especial reference to the diagnosis of
gastric carcinoma# Smears prepared from gastric
washings showed characteristic fluorescence in 77$
from gastric carcinomas, and 4$ from control cases
prepared with TC, hut none could he seen in either
group if TG had not heen given. Standard cytological
examination showed malignant cells in only one-third,
of carcinomas studied and none in the controls.
Analysis of results has heen made with regard to
tumour type and differentiation and the TC regime
employed. Scrupulous attention to detail must he
paid if fallacious results are to he avoided.
The published reports on the gastric
fluorescent test have heen analysed and in general
the results obtained in the larger series were
similar to xay own. The critics of the test have
reported small numbers and it is thought that their
inexperience in recognition of the typical fluoresc¬
ence may have led to their poor results.
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The value of the fluorescent test has been
assessed in relation to large collected analyses of
other diagnostic methods. Cytology, radiology and
gastroscopy may each lead tc a correct diagnosis in
two-thirds to three-quarters of gastric carcinomas,
as can the TC fluorescent test on gastric washings.
The proportion of false malignant diagnoses in
benign diseases for each of these techniques is
similar to that of the fluorescent test.
The principle of the test has been
extended to include the examination of sputum,
effusions, colonic washings and duodenal juices.
My own limited experience with sputum, pleural
effusions and ascites has been presented and the
published series reported, with the suggestion that
TC fluorescence may have wider applications in tumour
diagnosis.
The TC fluorescent test has been shown to
have a place in the diagnosis of malignant disease,
particularly of the stomach and perhaps of other
organs. It may be combined with cytology to obtain
maximum information from exfoliated material and has
the advantage in not needing a skilled cytologist for
its interpretation.
Finally, the possible future therapeutic
implications of TC binding by tumours have been
discussed with reference to the published reports of




CONTROL GROUP OP NON-MALIGNANT DISEASE
- PREPARER WITH TETRACYCLINE (see Page 31.)
1* Mr. S. A. Age 66.
Presented with features of colonic obstruction.
TC 1000 mg» intravenous over 30 minutes.
Interval 2 days
Fluorescence of opened excised pelvic colon - NIL
Histology - Acute Diverticulitis.
2* Mr. B.M. Age 23
Presented with symptoms of chronic small bowel
obstruction and a mass in R.I.F,
1000 fflg* intravenous over 30 minutes.
Interval 4 days
Fluorescence of excised ileal mucosa and thickened
ileal wall - NIL.
No fluorescence of several fleshy lymph nodes but
one gritty hard obviously calcified lymph node
showed moderate yellow fluorescent streaks.
Histology - Crohn's Disease of Ileum
3. Mr. F.J. Age 55
Presented with haematernesis and melaena. Ba
meal suggested antral ulceration.




Fluorescence of partial gastrectomy specimen - NIL.
Histology - Marked Antral Gastritis and
Intestinal Metaplasia,
4. Mrs. F.P. Age 51.
Had radiotherapy at same time as course of TC
3 months earlier for presumptive carcinoma breast
at another hospital.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 3 months
Fluorescence - extremely weak traces of yellow
in sectioned specimen.
Histology - Chronic Mastopathia with cyst
formation and granulation tissue.
No evidence of malignancy.
5. Mrs. L.W. Age 43
Presented with lump in breast.
TC 500 mg. q.d.s. x 5 doses. Total 2500 mg.
Interval 26 hours
Fluorescence of excised mass - v/eak powdering of
ellow fluorescence on lining of cyst.
Histology - Mastopathia with dense connective
tissue with distorted ducts and
intraluminal proliferation.
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Mrs. P.H. Age 50.
Presented with, lump in breast.
TC 500 rug. 4 hourly x 6 doses. Total 5000 mg.
Interval 26 hours
Fluorescence of excised mass - weak strands of
yellow fluorescence.
Histology - Mastopathia - condensation of
intralobular connective tissue
and extensive duct proliferation.
Mr. J.S. Age 42
Presented with lump in breast.
TC 500 q.d.s. for 4 days. Total 8000 mg.
Interval 28 hours
Fluorescence of opened cyst - weak powdering of
yellow fluorescence on inside of cyst wall.
Otherwise NIL.
Histology - Retention Cyst covered with dense
fibrous tissue and infiltration of
inflammatory cells, some ducts
with stasis and round-cell infiltration.
Mastopathla
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ters. S.I. Age 50.
Presented with lump in breast.
TC 500 mg. q.d.s. for 3 days. Total 6000 irig.
Interval 30 hours
Fluorescence of incised mass - NIL.
Histology - Mastoyathla with duct proliferation.
9* Mr. T.F. Age 69.
Presented with cough and chest X-ray showing
patchy atelectasis.
TC 500 mg. 4 hourly x 6. Total 3000 mg.
Interval 24 hours
Fluorescence of bronchial biopsy fragments - NIL.
Histology - Unstable Metaplasia
but no malignancy.
10. Mrs. E.W. Age 73
Presented with warty area on tongue,
Pre-TC - NIL fluorescence in vivo.
1000 mg. intravenous over 1 hour.
Interval 24 hours
Fluorescence in vivo and biopsy - NIL.
Histology - Simple Keratosis.
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11. Mrs» L.M. Age 79
Presented with lump of thigh for 1 year.
TC 500 mg. 4 hourly x 6 doses. Total 3000 mg.
Interval 30 hours
Fluorescence of lump - NIL.
Histology - Lipoma.
12. Mr. G.A. Age 65
Presented with dyspepsia for 4 years with lesser
curve GU on Ba meal.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 36 hours
Fluorescence of gastrectomy specimen - NIL of
ulcer crater nor of cut edge.
Histology - Benign Chronic Gastric Ulcer.
13* Mrs. A.B. Age 56
Presented with vomiting and dyspepsia for 9
months with large ulcer on posterlal wall of
stomach on Ba meal.
TC 500 mg. q.d.s. for 2| days. Total 5000 mg.
Interval 30 hours
Fluorescence of gastrectomy specimen - NIL of
ulcer crater nor of cut edge.
Histology - Benign Chronic Gastric Ulcer.
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14. Mrs. J.K. Age 53.
Presented with 3/52 pain, vomiting and anorexia.
Ba meal showed fairly large GU on high posterior
wall of stomach with possibility of malignancy.
TC 500 mg. q.d.s. for 2% days. Total 5000 mg.
Interval 36 hours
Gastric lavage - no fluorescence.
Further-interval of 25 hours
Fluorescence of Gastrectomy specimen - NIL of
ulcer crater nor of cut edge.
Histology - Benign Chronic Gastric Ulcer.
15. Mrs. R.S. Age 72.
Presented with 5 year history of dyspepsia and
proven gastric ulcers.
TC 500 mg. q.d.s. for 3 days. Total 6000 mg.
Interval 36 hours
Gastric lavage - no fluorescence. No malignant
cells seen.
Further interval of 28 hours
Fluorescence of gastrectomy specimen - NIL of
ulcer crater nor of cut edge.
Histology - Benign Gastric Ulcer with
Atrophic Gastritis.
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Mr. F.h. Age 54
Presented with 2 year dyspepsia and weight loss.
Ba meal - large lesser curve ulcer with raised edge.
Gastroscopy appearances highly suspicious of
malignancy.
TC 500 mg. q.d.s. for 3 days. Total 6000 mg.
Interval 36 hours
Gastric lavage - no fluorescence. Ho malignant
cells seen.
Further interval of 24 hours.
Fluorescence of gastrectomy specimen - Nil of
surface nor of cut edge.
Histology - Benign Gastric Ulcer with extensive
Chronic Gastritis and
Intestinal Metaplasia.
17. Mr. S.C. Age 48
Presented with rectal bleeding.
Ba enema filling defect in descending colon.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 30 hours
Fluorescence of excised polyp - NIL on surface
nor at excised base nor on section.
Histology - Benign Colonic Polyp.
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18• Miss E.S. Age 51.
Presented with lump in breast.
TC 500 mg. q.d.s. for 2| days. Total 5000 mg.
Interval 52 hours
Fluorescence of excised mass - Nil.
Histology - Mastopathia with extensive duct
proliferation.
19. Mrs. Y.S. Age 58.
Presented with lump in breast,
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 34 hours
Fluorescence of excised mass - NIL except for
faint dusting of yellow fluorescence on inside
of cyst wall.
Histology - Mastopathia with duct proliferation
and some duct stasis, with a single
Ketention Cyst.
20. Mr. S.L. Age 50.
Presented with haemoptysis and fever. Chest
X-ray - NAD.
TC 250 mg. q.d.s. for 7 days. Total 7000 mg.
Interval 48 hours
Fluorescence of bronchoscopic biopsy - NIL.
Histology - Chronic Bronchitis.
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21• Mr* W*H» A&e 48•
Presented with bronchitis and haemoptysis.
TC 250 mg. q.d.s. for 7 days. Total 7000 mg.
Interval 24 hours
Fluorescence of bronchoscopic biopsy - NIL.
Histology - Chronic Bronchitis with some metaplasia.
22. Mrs. P.H. Age 29.
Presented with lump on wrist
TC 500 mg. 4 hourly x 6. Total 3000 mg.
Interval 24 hours
Fluorescence of excised cystic mass - NIL.
Histology - Simple Ganglion.
23* Mrs. J.T. Age 69.
Presented with constipation and dubious barium
enema,
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 4 days
Fluorescence of opened colon - NIL.
Histology - Diverticulitis.
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24* Mrs, J. P. Age 72.
Presented with rectal bleeding and dubious
barium enema.
1000 mg. IV over 2 hours.
Interval 34 hours
Fluorescence of opened colon and mass - NIL.
Histology - Liverticulitis with pericolic
extension.
25. Mrs. S.H, Age 52.
Presented with ulcer of leg for 2 years.
Fluorescence - NIL before TC.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Fluorescence during course of TC of ulcer in
vivo - showed weak but definite yellow
fluorescence.
Interval 24 hours - weak fluorescence of scab.
Interval 48 hours - fluorescence of ulcer (scab
having separated) - NIL.
No histology as clinically Varicose Ulceration
which healed completely with bed rest.
Appendix 2.
DETAILS OF MALICMAKT TUMOURS EXAMINED FOR TETRACYCLINE
FLUORESCENCE - SUMMARIZED IK TABLE 2.(page 35)
1. Mr* B.C. Age 74.
Presented with diarrhoea and rectal mass.
TC 1000 mg. intravenous over 8 hours.
Interval 64 hours
Fluorescence of excised opened rectum - weak
yellow fluorescence of floor, but cut edge of
ulcer showed brilliant yellow flecks.
Adjacent lymph gland cut surface - weak yellow
fluorescence.
Histology - Moderately well differentiated
Adenocarcinoma Rectum
Broder's Grade II. Duke's Class B.
Mr. J.M. Age 66.
Presented with rectal bleeding and abdominal
distension.
1000 intravenous over 6 hours.
Interval 24 hours
Fluorescence of opened excised rectum - nil of
ulcer surface and dubious of cut edge. Bote -
enormous hepatomegaly due to secondary deposits.




3* Mr, L.S. Age 46
Presented with rectal bleeding.
TC 1000 mg. intravenous over 1 hour.
Interval 66 hours
Fluorescence of opened excised rectum - moderate
yellow on surface of ulcer; brilliant yellow of
cut surface; brilliant in lymph node cut across.
Histology - Moderately well differentiated
Adenocarcinoma Rectum v/ith hyper-
chromatic cells lining well-formed
acini and tubules. Carcinoma in
adjacent lymph nodes.
Broder's Grade II. Duke's Class G.
4. Mrs. A.M. Age 66.
Presented v/ith diarrhoea and rectal bleeding.
TC 1000 mg. intravenous over 30 mins.
Interval 48 hours
Fluorescence of opened excised rectum - weak
yellow on surface, brilliant yellow on cut edge of
ulcer. Brilliant yellow in lymph node cut across.
Histology - Adenocarcinoma Kectum with well-formed
acini penetrating deeply into muscle
layers. Carcinoma in adjacent lymph
node.
Broder's Grade II. Duke's Class C.
Mr. T.B. Age 84.
Presented with recurrence of rectal tumour after
previous excision 2 years earlier.
TC 1000 intravenous over 2 hours.
Interval 40 hours
Fluorescence of opened resected rectum, moderate
yellow on surface, "brilliant on cut edge.
Histology - Well differentiated
Adenocarcinoma Rectum
Broder's Grade II.
Mr. K.W. Age 44.
Presented with rectal bleeding.
1000 mg. intravenous over 1 hour.
Interval 5 days
Fluorescence of opened resected rectum - nil on
surface of ulcer, moderate yellow of cut edge.
Histology - Well differentiated
Adenocarcinoma Rectum
Broder's Grade II. Duke's Class A.
Mr. J.A. Age 27
Presented with rectal bleeding.




Fluorescence of opened excised rectum - weak
yellow on ulcer surface, moderate yellow with
brilliant flecks of cut edge.
Histology - Moderately well differentiated
Adenocarcinoma Rectum
Broder's Grade II. Duke's Class C.
Mr. B.F. Age 87
Presented with rectal bleeding.
1000 mg. intravenous over 1 hour
Interval 48 hours
Fluorescence of opened excised rectum - nil on
surface of tumour, weak yellow on cut edge of ulcer.
Histology - Well differentiated
Adenocarcinoma Rectum.
Miss L.I. Age 80.
Presented with abdominal mass and bowel irregularity.
TO 250 mg. q.d.s. for 5 days orally. Total 5000 mg.
Interval 6 days
Fluorescence of excised mass of tissue, moderate
overall fluorescence with brilliant flecks and spots.
Histology - Well differentiated
Adenocarcinoma Colon
Broder's Grade II. Duke's Class B.
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10 • Mr. Tr.B. Age 66.
Presented with constipation and rectal bleeding.
1000 ing* intravenous over 4 hours.
Interval 5 days
Fluorescence of opened excised colon, nil of
efflorescent branches of tumour but moderate
yellow with intense flecks in base and in
adjacent lymph node.
Histology - Well differentiated
Papillomatous Adenocarcinoma Colon
Broder's Grace II. Puke's Class B.
11• Mr. W.S. Age 59*
Presented with constipation.
TC 1000 mg. intravenous over 4 hours.
Interval 5 days
Fluorescence of opened resected colon - weak
yellow on surface of ulcer, moderate yellow with
brilliant flecks in cut mass and lymph node.
Histology - Poorly differentiated
Carcinoma Colon
Broder's Grade III. Duke's Class C.
Lymph nodes invaded.
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12. Mr. V.R. Age 73.
Presented with diarrhoea.
TC 1000 mg. intravenous over 1 hour.
Interval 3 days
Fluorescence of opened excised colon - NO yellow
fluorescence but bright flecks of blue/white
fluorescence in areas of the cut tumour.
Histology - Well differentiated
Adenocarcinoma Colon
Broder's Grade II. Duke's Class B.
13. Mrs. K.G. Age 74.
Presented with anaemia, pain and mass in R.I.F.
1000 Pig* intravenous over 1 hour.
Interval 40 hours
Fluorescence of large mass of tumour, areas of
negative, moderate and brilliant yellow. Lymph
glands showed similar variation.
Histology - Well differentiated
Adenocarcinoma Caecum
with extensive spread.
Broder's Grade II. Duke's Class B.
200
Mrs. L.C» Age 65.
Presented with gross furgating carcinoma of breast.
Being treated with radiotherapy.
Before TC, no fluorescence in vivo. TC 500 mg.
stat. then 250 mg. q.d.s. orally for 7 days.
Total 7500 mg.
Interval (i) 48 hours - Fluorescence brilliant
generalised yellow in vivo of
ulcerated breast
(ii) 8 days - Moderate in vivo fluorescence
Histology - Carcinoma Breast.
Mrs. P.P. Age 71.
Presented with lump in breast.
TC 500 mg. 4 hourly x 6 orally. Total 5000 mg.
Interval 50 hours
Fluorescence of simple mastectomy specimen - nil
of surrounding breast tissue cutting into specimen
circumscribed moderate yellow fluorescence with
brilliant flecks.
Histology - Irregular islands of cancer cells in
dense connective tissue, the cells




16. Miss P.P. Age 64.
Presented having had mastectomy 2 years earlier,
recent ulcerating lumps in axilla and neck.
Before TC, no fluorescence on examination of
areas with ultraviolet
TC 250 mg. q.d.s. for 5 days orally. Total 5000 mg.
Fluorescence at end of course, moderate yellow neck




Histology - Heavily Keratinized
Squamous Cell Carcinoma Breast
Broder's Grade II.
17* Mrs. A.W. Age 60.
Presented with lump in breast.
TC 500 mg., 4 hourly x 5 orally. Total 2500 mg.
Interval 24 hours
Fluorescence of radical mastectomy specimen -
brilliant fluorescence of tumour tissue. Deep to
pectoralis major, strands of moderate fluorescence,
apparently lymph vessels with carcinoma.
Histology - Spheroidal Cell Carcinoma Breast with
marked scirrhous reaction. Lymph nodes
invaded. Patey-Scarff Grade II.
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18. Mrs. I.P. Age 51.
Presented with lump in breast.
TC 500 mg. 4 hourly x 6 orally. Total 5000 mg.
Interval 28 hours
Fluorescence of radical mastectomy specimen -
moderate yellow of tumour mass with brilliant
flecks.
Histology - Carcinoma Breast
Clumps of irregular vacuolated cells
in dense fibrous tissue.
19. Miss E.B. Age 72
Presented with lump in breast.
TC 500 mg. q.d.s. for 1 day. Total 20C0 mg.
Interval 24 hours
Fluorescence - moderate diffuse yellow of cut tumour
Histology - Spheroidal-cell Carcinoma Breast
Patey-Scarff Grade II.
20. Mr. A.G. Age 66.
Presented with lump of breast,
TC 1000 mg. intravenous over § hour.
Interval 48 hours
Fluorescence of cut tumour - patchy brilliant yellow
Histology - Carcinoma Breast (Male)
little tendency to form tubules,
abundant fibrous reaction.
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21* Mrs. L.H. Age 83
Presented with lump in breast.
TC 500 mg. 4 hourly x 4. Total 2000 mg.
Interval 24 hours
Fluorescence of simple mastectomy specimen -
moderate diffuse yellow with brilliant streaks
of cut tumour (SEE PHOTOGRAPH A).
Histology - Adenocarcinoma Breast with good deal
of intraluminal proliferation, but also
scirrhous reaction and much proliferation
by single cells and small groups.
Patey-Scerff Grade II,
22* Mr* J.S. Age 73
Presented with loss of weight and dyspepsia.
TC 250 mg. q.d.s. for 5 days orally. Total 5000 mg.
Interval 30 hours - gastric lavage - no fluorescence
of deposit.
Interval to operation 44 hours.
Fluorescence of excised stomach ~ cut surface
brilliant yellow, but only faint blotch of reddish
yellow on mucosal surface.
Histology - Adenocarcinoma of Stomach - Linitis
Plasties,
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23* Mr. P.M. Age 52
Presented with dyspepsia.
TO 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval of 56 hours to gastric lavage - no
fluorescence of deposit.
Interval to gastrectomy 60 hours
Fluorescence - Dubious traces of yellow cn
surface and cut edge of tumour.
Histology - Carcinoma Stomach
Mass of oedematous connective tissue
with numerous signet-ring type
cancer cells.
24« Mrs. M.CU. Age 67
Presented with anaemia.
TC 500 mg. q.d.s. orally for 2-§- days. Total 5000 mg.
Interval 36 hours to gastric lavage - very gentle
because much altered blood - no fluorescence.
Interval 11 days to gastrectomy.
Fluorescence of tumour - NIL.
Histology - Well differentiated ulcerated
Adenocarcinoma Stomach
25. Mr. H.F. Age 64.
Presented with loss of weight and abdominal pain.
TC 500 q.d.s. orally for 2j> days. Total 5000 mg.
Interval 3b hours
Gastric lavage - moderate spots of yellow
fluorescence.
Interval before gastrectomy - 60 hours
Fluorescence of excised stomach - moderate of
ulcerated surface of tumour and moderate of cut edge
Histology - Flat, thick, ulcerated anaplastic
Carcinoma of Stomach.
26. Mr. J.M. Age 60
Presented with headache, vomiting and signs of
intracranial tumour with collapsed lobe on chest
X-ray. Bronchoscopy - negative.
TC 500 mg. q.d.s. orally for 3 days. Total 6000 mg.
Interval 18 days
Fluorescence brilliant yellow of autopsy material
from lung (brain not examined).
Histology - Oat-cell Carcinoma Bronchus
27. Mr. A.P. Age 62
Presented for investigation of collapsed right upper
lobe of lung.
TC 500 mg. 4 hourly x 5 orally. Total 2500 mg.
Interval - 25 hours
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27. cont.
Fluorescence - weak yellow of bronchial biopsy
fragment smeared on slide.
Histology - Oat-cell Carcinoma Bronchus
28. Mrs. h.W. Age 64
Presented with confusion and hilar mass on chest
X-ray.
TC 500 mg. q.d.s. for 2| days. Total 5000 mg.
Interval 50 hours
Fluorescence of smear of fragment of bronchoscopic
biopsy - brilliant yellow.
Histology - Squamous Cell Carcinoma Bronchus
29. Mr. J.W. Age 60
Presented with haemoptysis.
TC 500 mg. q.d.s. orally for days. Total 5000 mg.
Interval 50 hours
Fluorescence of smear of fragment of bronchial
biopsy - Nil.
Histology - Oat-cell Carcinoma Bronchus
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30. Mr. K.C. Age 61
Presented with discharging anal mass.
TC 1000 mg. intravenous over 8 hours.
Interval 70 hours
Fluorescence of opened excised rectum and anus
- nil of ulcer surface but moderate diffuse
yellow with bright flecks on cut edge.
Histology - Squamous Carcinoma of Anal Canal
BrOder's Grade II.
51* Mr. W.L. Age 58.
Presented with painful ulcerating prepuce.
Before TC no fluorescence on examination of penis
with ultraviolet lamp.
TC 500 mg. 4 hourly x 6 orally. Total 5000 mg.
Fluorescence in vivo at end of course of TC -
brilliant yellow on all raw surfaces.
Interval 30 hours
Fluorescence of excised prepuce - spots of
brilliant yellow on some ulcerated and cut
surfaces, otherwise moderate intensity of
ulcerated areas.
Histology - Squamous Carcinoma of Prepuce
Broder's Grade II,
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32* Mr. D.T. Age 65
Presented with, ulcer on amputation stump.
TC 1000 mg> intravenous in 1 hour.
Interval 28 hours •
Fluorescence of surface of ulcer - weak yellow,
moderate yellow of cut tumour. Scraping from
subjacent marrow cavity negative.
Histology - Well differentiated
Squamous Cell Carcinoma Skin
Marrow scraping showed no malignancy.
33. Mrs. A.P. Age 75
Presented with enlarging ulcer of leg for years.
Received radiotherapy prior to TC.
Before TC no fluorescence on examination with
ultraviolet lamp.
TC 250 mg. q.d.s. for 10 days orally. Total 10.000 mg.
Interval 48 days
Fluorescence - brilliant yellow patches over
ulcerated area in vivo.
Histology - Basal Cell Carcinoma of Skin
34. Miss M.E. Age 87
Presented with enlarging ulcer of cheek.
Being treated v;ith radiotherapy.
Before TC no fluorescence in vivo.




Fluorescence - diffuse moderate of ulcer in vivo
Histology - Basal Cell Epithelioma of Cheek.
55. Mr. J.B. Age 39
Blalignant melanoma of leg removed l-£ years earlier.
Presented with swelling in groin.
Tc 1000 nig, intravenous over 4 hours.
Interval 48 hours
Fluorescence of cut glands - nil.
Histology - Replacement of glands by
Malignant Melanoma.
36. Mrs, P.H. Age 69.
Presented with loin mass and pain.
TC 500 mg. q.d.s. for 4 days orally. Total 8000 mg.
Interval 8 days
Fluorescence - variable intensity from moderate
'fco brilliant through whole mass of tissue.
Histology - Transitional Cell Carcinoma
of Renal Pelvis
with papillary overgrowth of pelvic
epithelium and extensive invasion of
kidney and surrounding tissues.
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37. Mrs. M.Cl. Age 60
Presented with pain, mass in loin and cachexia.
TC 250 q.d.s. for 7 days orally. Total 7000 mg.
Interval 48 hours - then died.
Fluorescence of large mass of tissue at autopsy
- patchy varying from nil to brilliant.
Histology - Fairly well differentiated
Papillary Adenocarcinoma of Kidney
with fairly extensive necrosis.
38. Mr. H.V. Age 59.
Presented with parotid swelling.
TC 500 mg, 4 hourly x 4 orally. Total 2000 mg.
Interval 30 hours
Fluorescence of tumour fragments - moderate
yellow.
Histology - Salivary Carcinoma
with low-grade sialadenitis and
tumour tissue in the form of cords
and islands of rather dark cells




39. Mr. E.P. Age 79.
Presented with lump in cheek ulcerating into mouth
TC 500 mg. x 2 orally, then patient had stroke, then
200 mg. by intramuscular injection x 8. Total 2600 mg.
Interval 24 hours then death.
Fluorescence of autopsy fragment - brilliant yellow.
Histology - Carcinoma of Salivary Gland
Infiltration of subepithelial tissues
by irregular masses of cells resembling
epidermal basal cells,
40. Mr. S.C. Age 68
Presented with tumour of jaw ulcerating into the
mouth. Being treated with radiotherapy.
Before TC no fluorescence on examination of mouth
with ultraviolet lamp.
TC 500 mg. stat., then 250 mg. q.d.s. orally for
7 days. Total 7,500 mg.
Interval (i) 36 hours - Fluorescence moderate
diffuse yellow in vivo
(ii) Q days - Fluorescence moderate
diffuse yellow post mortem.
Histology - Chondrosarcoma of Mandible
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Appendix 3.
DETAILS OF TETRACYCLINE FLUORESCENT TEST IN GASTRIC LAVAGE
OF MALIGNANT TUMOURS - SUMMARIZED IN TABLE 4 (page 110.)
1. Mr. W.F. Age 78
Presented with 5 months' dyspepsia, anorexia and
loss of weight.
Ba. meal - large tumour in upper half of stomach.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 36 hours
lavage fluorescence - brilliant smears.
Cytology - "some suspicious atypical cells"
suggestive of squamous cell carcinoma.
Gastrectomy - Ulcerated, well differentiated,
papilliferous Adenocarcinoma
2« Mrs. R.B. Age 61.
Presented with 2-§- years' dyspepsia.
Ba. meals - had two li- years earlier - HAD.
- third shewed tumour mass in mid-gastric
region.
TC 500 ing. q.d.s. for 2■§■ days. Total 5000 mg.
Interval 36 hours
Lavage fluorescence - moderate streaks and flecks.
Cytology - "suspicious atypical cells"
Laparotomy - inoperable tumour. Gland biopsy -
very poorly differentiated Adenocarcinoma
Mrs, W.W. Age 65.
Presented with 2 months* anorexia, epigastric pain
and weight loss.
Ba. meal - large mid-gastric tumour.
TC 500 mg. q.d.s. for 2-§ days. Total 5000 mg.
Interval 30 hours
Lavage fluorescence - NIL.
Cytology - no malignant cells.
Gastrectomy - Anaplastic carcinoma of the
linitis plastica type with no
mucosal invasion.
Mr. H.F. Age 64. (= Case 25. Appendix 2)
Presented with 8 months' weight loss, epigastric
pain and epigastric mass.
Ba. meal - pyloric filling defect.
Lavage fluorescence before TC - NIL.
TC 500 q.d.s. for 2% days. Total 5000 mg.
Interval 56 hours
Lavage fluorescence - moderately intense spots.
Cytology - no malignant cells.
Gastrectomy - flat thick antral anaplastic carcinoma.
Fluorescence of tumour - moderate
intensity.
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5* Mr. P.O. Age 55.
Presented with 6 months1 weight loss and vomiting.
Lavage fluorescence before TC - NIL.
Ba. meal - pyloric filling defect,
TC 500 mg. q.d.s. for 2% days. Total 5000 mg.
Interval 56 hourE
Lavage fluorescence - wealc flecks.
Cytology - no malignant cells.
Gastrectomy - large ulcerated poorly differentiated
Adenocarcinoma
6. Miss C.W. Age 54.
Presented with 8 months' weight loss and anaemia.
Ba. meal - rigid lesser curve.
TC 250 q.d.s. for 5 days. Total 5000 mg.
Interval 36 hours
Lavage fluorescence - weak flecks.
Cytology - no malignant cells.
Gastrectomy - well differentiated papilliferous
Carcinoma.
Mr. G.S. Age 74.
Presented with 2 years' weight loss and anorexia.
Ba. meal - irregular filling defect in upper of
stomach.
TC 500 mg. q.d.s. for 2| days. Total 5000 mg.
Interval 32 hours.
cont.
Lavage fluorescence - few weak flecks.
Cytology - not performed.
laparotomy - obvious inoperable gastric malignancy.
Mo biopsy.
Mr. A.A. Age 60.
Presented with 6 months' weight loss and dyspepsia.
Ba. meal - very extensive infiltration and filling
defects of body of stomach.
TC 1000 mg. intravenous over 4 hours.
Interval 48 hours
Lavage fluorescence - brilliant smears.
Cytology - "neoplastic cells present"•
ho operation and died of carcinomatosis with hepatic
metastases,
Mr. A.K. Age 56.
Presented with 5 months' weight loss and dyspepsia.
Ba. meal - very extensive malignancy of body of
stomach.
1000 mg. intravenous over hour.
Interval 40 hours
Lavage fluorescence - few flecks of moderate intensity.
Cytology - not performed.
Laparotomy - inoperable malignant growth of stomach.
Mo biopsy.
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Mr. F. Wa. Age 80.
Presented with 6 months weight loss and dyspepsia.
Ba. meal - large fundal filling defect.
Lavage Before TC - no fluorescence.
TC 500 mg. q.d.s. for 4 days. Total 8000 mg.
Interval 36 hours
Lavage fluorescence - small spots of moderate
intensity.
Cytology - not done.
Ho operation as too ill. Med after clinical
course of carcinoma.
11• Mr. P.M. Age 60. (= Case 23, Appendix 2.)
Presented with 6 months' dyspepsia.
Ba. meal - mid-gastric tumour.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 36 hours
Lavage fluorescence - MIL.
Cytology - not performed.
Gastrectomy - much connective tissue with many
separate "signet-ring" type of
cancer cells. Dubious
fluorescence of excised tumour.
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12. Mrs. M.C. Age 67. (= Case 23» Appendix 2.)
Presented with iron-deficiency anaemia.
Ba. meal - mid gastric plaque.
Gastroscopy - irregular ulcer probably malignant.
TC 500 mg. q.d.s. for 2\ days. Total 5000 mg.
Interval 36 hours
Lavage fluorescence - NIL but vigorous lavage not
performed because of bleeding.
Cytology - no malignant cells.
Gastrectomy - well differentiated ulcerated
Adenocarcinoma. No fluorescence
of excised tumour.
13* Mr. T.S. Age 49.
Presented with 1 year's anorexia, weight loss and
dyspepsia.
Ba. meal - large antral papuliferous neoplasm.
Lavage fluorescence before TC - NIL.
1000 Kg* IV over 4 hours.
Interval 36 hours
Lavage fluorescence - few spots of moderate intensity.
Cytology - no malignant cells.
Laparotomy - inoperable neoplasm. Biopsy poorly
differentiated mucoid Adenocarcinoma.
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3-4. Mr. B.B. Age 55.
Presented with 2 years' dyspepsia.
Ba. meal - large flat lesser curve ulcer.
Gastroscopy - mid-gastric contraction with plaque.
TC 250 mg. q.d.s. for 5 days.. Total 5000 mg.
Lavage fluorescence - NIL.
Cytology - no malignant cells.
Gastrectomy - malignant ulcer with poorly
differentiated mucoid
Adenocarcinoma.
3-5. Mr. F. Wo Age 60.
Presented with recent epigastric pain and weight
loss. Gastroenterostomy 15 years earlier.
Ba. meal - funda.1 filling defect.
Gastroscopy - good view not obtained,
TC 500 mg. q.d.s. for 4 days. Total 8000 mg.
Interval 36 hours
Lavage fluorescence - few flecks of moderate intensity.
Cytology - no malignant cells seen.
No operation. Died of progressive anaemia, cachexia
and hepatic metastases.
16. Mr. F.E. Age 69.
Presented with 6 months' dyspepsia and weight loss.
Ba. meal - probable gastric carcinoma with rigid
lesser curve.




Lavage fluorescence - brilliant smears.
Cytology - not performed.
Laparotomy - inoperable malignant tumour of
stomach. No biopsy.
17* Mr. J.S. Age 73. (= Case 22, Appendix 2.)
Presented with 4 months' dyspepsia, and weight loss.
Ba. meal - rigid stomach.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 30 hours
Lavage fluorescence - NIL.
Cytology - not performed.
Gastrectomy - Adenocarcinoma of stomach of
linitis plasties type. Fluorescence
of excised stomach - cut surface
brilliant but only faint blotch of
reddish yellow in mucosal surface.
18• Mrs. L.J. Age 50.
Presented with 18 months' anaemia and 2 months' pain
and vomiting.
Ba. meal - NAB.
Gastroscopy - rigid antrum with an ulcer.




Lavage fluorescence - weak flecks.
Cytology - no malignant cells.
Gastrectomy - poorly differentiated ulcerated
Carcinoma of Stomach.
19* Mrs, D.H, Age 68.
Presented with 4 months' abdominal pain and
weight loss.
Ba. meal - extensive malignancy of stomach.
TC 500 mg. q.d.s. for 2-k days. Total 5000 mg.
Interval 30 hours.
Lavage fluorescence - few flecks of moderate intensity
Cytology - no malignant cells.
Gastrectomy - poorly differentiated ulcerated
Adenocarcinoma of Stomach.
20. Miss S.M. Age 72.
Presented with 8 months' loss of weight and recent
haematemesis.
Be. meal - extensive tumour of stomach.
TC 250 q.d.s. for 5 days. Total 5000 mg.
Interval ^2 hours. Cytology — malignant cells present.
Lavage fluorescence - brilliant flecks end smears.
Laparotomy - extensive inoperable malignant
tumour of stomach. No biopsy.
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21• Mr, S.L. Age 68,
Presented with recent malaise. Treated pernicious
anaemia for 5 years,
Ba, meal - tumour involving fundus and pars media.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 50 hours
Lavage fluorescence - NIL.
Cytology - not performed.
Gastrectomy - poorly differentiated
Adenocarcinoma of Stomach of
the ulcerated polypoidal type.
22» Mrs. E.g. Age 55.
Presented with 10 months* dyspepsia.
Ba, meal - extensive infiltration of upper part of
stomach.
TC 500 mg. q.d.s. for 2^ days, Total 5000 mg.
Interval 50 hours
Lavage fluorescence - flecks of moderate intensity.
Cytology - malignant cells present.
Palliative oesophago-jejunal anastomosis. No
histology of the malignant disease.
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23. Mr. J.O. Age 58.
Presented with 4 months* loss of weight and
vomiting*
Ba* meal - constant pyloric narrowing and
irregularity*
Lavage fluorescence before TC - NIL.
1000 rag* intravenous over 1 hour.
Interval 30 hours
Lavage fluorescence - occasional weak flecks.
Cytology - no malignant ceils.
Laparotomy - inoperable malignancy of stomach with
peritoneal deposits. No histology.
24. Mr. S.A. Age 63.
Presented with 5 months* loss of weight, epigastric
pain and ascites.
Ba. meal — extensive filling defects of body of
stomach.
Gastroscopy - ulcerated neoplastic mass.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 30 hours
Lavage fluorescence - moderately intense smears
and flecks.
Cytology - no malignant cells.
No operation in view of ascites.
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25* Miss L.D» Age 75*
Presented with 9 months loss of weight, pain and
vomiting.
Ba. meal - polypoidal mid-gastric mass.
1000 mg« intravenous over 1 hour.
Interval 32 hours
lavage fluorescence - brilliant smears and flecks.
Cytology - many clumps of malignant cells.
Ho operation in view of hepatomegaly.
26» Mrs. P.W. Age 80.
Presented with 1 years* cachexia, anorexia,
abdominal pain and vomiting.
Ba. meal - extensive neoplastic ulcer.
1000 mg» intravenous over 1 hour.
Interval 30 hours
Lavage fluorescence - moderate flecks.
Cytology - not performed.
Ho operation in view of age and poor condition.
Med shortly after but no autopsy.
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27. Mr. A.C. Age 73.
Presented with 9 months' anorexia and loss of
weight.
Ba. meal - infiltrating neoplasm of "body of stomach.
TO 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 30 hours.
Lavage fluorescence - brilliant smears.
Cytology - not performed.
Bo operation in view of hepatic metastases.
28 • Mr. A.L. Age 44.
Presented with 6 months' anorexia and dyspepsia.
Ba. meal - suspicious of mid-gastric tumour.
Lavage fluorescence before TC - KIL.
TO 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 32 hours
Lavage fluorescence - brilliant flecks and smears.
Cytology - not performed.
Laparotomy - widespread peritoneal metastases
from neoplasm of stomach.
No biopsy.
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29« Mrs. M.W. Age 65*
Presented with anaemia and 3 months' loss of
weight.
Ba. meal - obvious large fungating tumour of
body of stomach.
TC 500 mg. q.d.s. for 2| days. Total 5000 mg.
Interval 50 hours
Lavage fluorescence - brilliant smears and
flecks.
Cytology - not performed.
Laparotomy - inoperable tumour of stomach.
No biopsy.
50. Mr. J.J. Age 69.
Presented with 6 months' dyspepsia and anorexia.
Ba. meal - mid-gastric malignant ulcer.
TC 250 mg. q.d.s. for 5 days. Total 5000 mg.
Interval 50 hours
Lavage fluorescence - NIL.
Cytology - not performed.




Photograph A taken under ordinary photo¬
graphic illumination compared with ultraviolet
illumination in a dark room, illustrates the
difficulty of obtaining contrast on black-ana-white
film between golden-yellow fluorescence and. reflected
points of light from the small amount of visible
light allowed through the filter paper of the ultra¬
violet lamp.
Colour photographs of the gastric lavage
smears were attempted by the Hospital Photographer
at King's College Hospital, using Kodachrome 2 film,
a Wratten 85B filter over an f5»6 lens situated
immediately behind the ultraviolet lamp, which was
4 to 6 inches from the smears. Colour processing
and printing does not demonstrate the true golden-
yellow fluorescence which appears pale green on the
prints.
Cut tumour seen









2.0 gm. TC orally.













Letters "TC" drawn on white paper with a weak
solution of TC. When viewed by ordinary light,
the letters were invisible, but under ultraviolet
light, fluoresced a bright golden-yellow,
although colour reproduction gives a rather
green appearance.
PHOTOCxRAPH C.
Three smears from gastric lavage on strips of filter
paper. All three patients previously prepared with TC.
Prom left to right:-
Smear 1. Two small smears and two flecks of character¬
istic TC fluorescence of moderate intensity
Prom Case 15, (Appendix 3*5 - from patient
with carcinoma of fundus of stomach.
Smear 2. White fluorescence - not golden-yellow - from
patient with benign gastric ulcer.
Negative result.




Smear on glass slide from gastric lavage
of Case 20 (Appendix 3.), a patient with
extensive inoperable gastric malignant
disease, showing positive fluorescent
result of brilliant intensity.
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